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 CHRONIC STRESS, INFLAMMATION, AND PROGRESSION OF CAROTID 
ARTERY ATHEROSCLEROSIS: A MEDIATION MODEL 
Denise L. Janicki, Ph.D. 
University of Pittsburgh, 2006
Psychosocial stress might account for some of the variance in cardiovascular disease (CVD) risk 
that is not explained by traditional risk factors.  Most studies of stress and CVD have focused on 
(a) stress in a single life domain, and (b) clinical CVD outcomes.  Few studies have examined 
physiologic mechanisms that might explain the association between stress and CVD.  The 
primary aim of the present study was to examine whether:  (1) chronic stress predicts changes in 
carotid artery intima-media thickness (IMT) and plaque; and (2) the association between chronic 
stress and changes in these surrogate CVD endpoints is mediated by inflammatory processes.  A 
secondary aim was to investigate whether individual differences in cardiovascular reactivity 
(CVR) moderates the association between stress and changes in IMT and plaque.  The sample 
(n=276; M age=60.5), was a subset of the Pittsburgh Healthy Heart Project, a longitudinal 
investigation of the effects of psychosocial and biological risk factors on surrogate CVD 
endpoints among healthy older adults.  Chronic stress was assessed at baseline with the Chronic 
Stress Scale (CSS; Norris & Uhl, 1993), a self-report survey that measures stress in 7 life 
domains during the preceding 6 months.  Chronic stress was computed in terms of (a) scores on 
the 7 CSS subscales and (b) average score across all 7 subscales.  Ultrasound IMT measures 
were taken at baseline and 3 years later.  Mean IMT was derived by taking the bilateral average 
of far wall common, internal and bulb measures.  IMT change was computed as the arithmetic 
difference between follow-up and baseline values.  Plaque change was computed as the number 
of visible lesions at follow-up less the number of lesions at baseline.  Blood draws for 
inflammatory markers and CVR testing were conducted at separate baseline visits.  Results failed 
to support the mediation model.  Only the CSS physical stress subscale was an independent 
predictor of IMT change (b=.02, t=2.13, p=.03).  CSS scores were unrelated to plaque, or to 
inflammatory marker levels.  Results did not differ according to CVR.  Findings question the 
importance of chronic stress, as measured by global self-report, as a predictor of change in IMT 
and plaque.  
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1.0        INTRODUCTION 
1.1 OVERVIEW 
Cardiovascular disease (CVD) is a long-term, progressive condition of multifactorial etiology.  
Much of the variance in prevalent CVD can be attributed to the presence of various biomedical 
risk factors, such as hypertension, hypercholesterolemia, and diabetes mellitus, in addition to 
behavioral factors such as smoking and lack of physical activity.  The importance of modifying 
these traditional risk factors in the treatment and prevention of CVD is undisputed.  However, 
there is evidence to suggest that traditional risk factors alone do not account for all CVD risk 
(Futterman & Lemberg, 1998; Hackam & Anand, 2003).  Given that approximately 650,000 
United States citizens per year are expected to experience a new acute coronary event, with 47% 
of those attacks being fatal (American Heart Association, 2003), even modest estimates of 
variance in CVD that cannot be explained by traditional risk factors represent a substantial 
population of persons whose early signs of disease are likely to be overlooked.  From a public 
health standpoint, then, identification of novel CVD risk factors may improve the ability to 
detect preclinical CVD, and thus potentially lower clinical CVD burden at the level of the 
population. 
It has been postulated that psychosocial factors, in particular the experience of 
psychosocial stress, might account for some of the unexplained variance in CVD morbidity 
(Krantz & McCeney, 2002; Rozanksi, Blumenthal, Davidson, Saab, & Kubzansky, 2005).  
Results from the INTERHEART study, for example, have shown that CVD risk associated with 
psychosocial factors, including perceived stress, is comparable to that associated with other more 
traditional risk factors such as hypertension, abdominal obesity, and smoking (Yusuf et al., 
2004).  It should be noted that the INTERHART study, like the majority of investigations that 
have reported prospective associations between stress and CVD risk, have focused on the 
prediction of clinical disease endpoints, such as myocardial infarction (MI) and cardiovascular 
  1
death.  Taken at face value, then, one might conclude from the findings of extant research that 
exposure to chronic stress increases individuals’ susceptibility to experiencing an acute event.  In 
other words, psychosocial stress might influence CVD risk by facilitating the transition form 
asymptomatic subclinical pathology to symptomatic clinical disease.   
That chronic stress appears to play a role in the transition to clinically manifest disease 
does not exclude the possibility that stress influences CVD risk at earlier stages in the disease 
process as well.  For example, exposure to chronic stress might be associated with (1) the 
initiation of biologic processes that are fundamental to initial atherosclerotic lesion development, 
or (2) the progression of fatty streaks to more advanced plaques.  The following discussion will 
focus on the possible role of psychosocial stress in these early disease processes, particularly 
those aspects of early CVD pathology that can be represented by changes in intima-media 
thickness and development of atherosclerotic plaque. 
Chronic stress exposure may have direct effects on disease progression by exhausting 
biological resources or by activating a continually aroused state.  Alternatively, exposure to 
chronic stress also may have indirect effects on health via failed coping efforts or deteriorated 
health behaviors (Lepore, 1995).  The role of behavioral factors, such as poor diet and 
participation in high-risk activities (e.g., smoking), is considerable.  However, associations 
between psychosocial stress and CVD risk frequently persist independent of the effects of such 
behavioral influences (Manuck, Marsland, Kaplan, & Williams, 1995).  Thus, it is of interest to 
identify plausible physiologic mechanisms that might provide a direct pathway by which 
psychosocial stress could influence CVD pathogenesis.  One proposed mechanism involves 
activities of immune and inflammatory processes.    
The following pages provide a rationale for investigating inflammation as a physiologic 
mechanism by which the experience of psychosocial stress might be translated into 
cardiovascular pathology.  The discussion begins with an overview of existing human and 
comparative research that has observed an association between exposure to chronic psychosocial 
stress and development of CVD-relevant outcomes.  The discussion then will proceed to review 
existing literature supporting the proposition that chronic stress may contribute to CVD 
pathogenesis via a mechanism involving underlying inflammatory activity.  Finally, the paper 
will conclude with the proposal of an empirical investigation that has been designed to examine 
the following research questions among a sample of healthy, older adults: (1) Is chronic stress 
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associated with pathophysiologic changes relevant to early CVD progression; and (2) Is that 
association mediated by ongoing low-grade inflammatory activity?  Prior to beginning this 
discussion, the pages to follow will examine the question of how best to define and measure the 
psychosocial construct, “stress.” 
1.2 CHRONIC STRESS AND CVD 
A fundamental challenge of stress and health research is the conceptualization and measurement 
of the independent variable.  Since Selye’s introduction of the term in the early part of the 
previous century, stress has been defined variously.  Central to most definitions is the notion of 
disrupted homeostasis as a function of poor fit between the individual and his or her environment 
(Menaghan, 1983).  Said differently, stress arises when demands imposed by the environment 
cannot be accommodated by the coping efforts of the individual (Lazarus & Folkman, 1984).  
“Coping,” for the present purposes, refers to deliberate behaviors that are enacted by the 
individual to reduce the threat associated with a given environmental stimulus (stressor).  
Associated with coping behaviors are automatic biological responses that compensate for stress-
related perturbations of the internal physiologic milieu.  An important caveat to the above 
definition of coping is that it is predicated upon the assumption that the individual consciously 
recognizes a given environmental stimulus as stressful.  Thus, stress might be construed as the 
outcome of 3 co-occurring processes: (1) stressor exposure; (2) stressor appraisal; and (3) 
response to the stressor (Lazarus & Folkman, 1984).  Stress so defined may influence physical 
health outcomes via either of the following pathways: insufficient responding and inappropriate 
responding.  In the former case, an inadequate response to toxic environmental stimuli increases 
the individual’s vulnerability to damaging effects associated with the stressor.  For example, an 
impaired immune response to invasion by an infectious pathogen increases susceptibility to 
bodily infection.  Alternatively, an inappropriate response to environmental stimuli that over-
compensates for associated effects also may contribute to the generation of a diseased state.  For 
instance, a protracted inflammatory response to infection or injury may result in damage to 
surrounding tissue.  Likewise, exaggerated heart rate response to fearful stimuli may contribute 
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to the creation of pathogenic conditions at the artery wall, thus predisposing susceptible 
endothelium to early atherosclerotic processes (Markovitz & Matthews, 1991).   
Given the different routes by which stress has been hypothesized to influence organic 
functioning and ultimately health outcomes, it is unsurprising that agreement on a standardized 
operationalization of the stress construct has proven difficult for researchers of stress and 
disease.  One point of contention concerns the importance of the appraisal process:  Is it 
necessary for an individual to perceive an environmental stimulus as stressful in order for 
physiologic responses (with the potential for pathophysiologic sequelae) to take place?  Another 
area of disagreement focuses on whether the effects of chronic stressors may be summated across 
life domains, or whether specific chronic stressors should be considered separately, thus allowing 
for examination of interactive effects.  The following section will discuss the strengths and 
weaknesses of several operationalizations of stress that have been examined as predictors of 
CVD-relevant outcomes among comparative animal and human populations.  
1.2.1 Comparative research 
One prominent paradigm that has been used to approximate stress among nonhuman animal 
species is social reorganization.  Briefly, this stressor involves rotation of experimental animals 
through unstable social groupings that may or may not include exposure to a dominant or 
aggressive conspecific.  Given the communal nature of several animal species that are used in the 
laboratory (e.g., rodents, nonhuman primates) it is assumed that social reorganization constitutes 
an aversive environmental challenge that likely would elicit a physiologic stress response.  This 
assumption is supported by findings of elevated beta-adrenergic activity among laboratory 
animals that have been exposed to unstable social conditions (Henry, Meehan, & Stephens, 
1967).   
The relevance of social reorganization to coronary disease has been demonstrated by a 
series of studies that were conducted among cynomolgus macaques (J. R. Kaplan, Adams, 
Clarkson, & Koritnik, 1984; J. R. Kaplan, Manuck, Clarkson, Lusso, & Taub, 1982; J. R. Kaplan 
et al., 1983).  Among male macaques that had been fed a moderately atherogenic diet (i.e., 
comparable to typical Western diet), assignment to an unstable social condition was unrelated to 
atherogenesis (Kaplan et al, 1982).  However, a significant stress-by-social status interaction 
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revealed that dominant macaques that were assigned to the unstable condition developed the 
most advanced atherosclerosis when measured in terms of intima-media thickness and lumen 
diameter (Kaplan et al, 1982).  These findings were independent of the effects of serum 
cholesterol.  However, to rule out the potential influence of the hyperlipidemic diet on 
atherogenesis, the authors replicated their study among a sample of male macaques that had been 
fed a “prudent” diet.  Results of this study indicated that macaques that were assigned to the 
unstable condition developed more extensive coronary atherosclerosis than macaques that were 
assigned to the stable condition (Kaplan et al, 1983)1.  In the third study, Kaplan and colleagues 
attempted to extend their findings among male macaques to females of the species.  Among 
female macaques that had been fed an atherogenic diet, there was a main effect for social status 
such that dominant females developed fewer raised coronary lesions than did their subordinate 
counterparts regardless of social condition (Kaplan et al, 1984).   
A major strength of the above nonhuman primate research is the choice of the 
cynomolgus macaque as a comparative model.  Macaques develop intimal, lipid-laden lesions 
that are similar in anatomic distribution to, and share pathologic characteristics with 
atherosclerotic lesions observed in humans.  Moreover, the social organization of macaques 
promotes the exhibition of aggressive and competitive behaviors that are reminiscent of anger 
and hostility, traits that have been associated with CVD in human research (Kaplan et al, 1985).   
Two important inferences might be drawn from the above comparative research.  First of 
all, the findings among macaques provide some indication of when during the disease process 
psychosocial stress might influence CVD.  That social reorganization stress anticipates coronary 
atherogenesis among nonhuman primates suggests that chronic psychosocial stressors have the 
capacity to influence CVD at early stages of disease progression.  A second conclusion that 
might be derived from this series of studies concerns the nature of chronic stressors that might 
influence CVD-relevant outcomes.  Though procedurally novel, social reorganization in the 
laboratory likely approximates a type of psychosocial stressor that nonhuman primates typically 
encounter as a part of their daily existence.  Thus, the above findings suggest that a stressor need 
be neither exceptional nor traumatic to contribute to CVD pathogenesis.  Extrapolating these 
associations to human populations, a reasonable hypothesis is that ongoing exposure to ordinary 
                                                 
1 The interaction with social status was not tested as the behaviors of this group of monkeys could not reliably be 
identified as dominant or subordinate.   
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stressors, or the “persistent hardships experienced by those engaged in mainstream activities 
within major institutions” (Pearlin & Schooler, 1978), may be sufficient to place individuals at 
risk for future CVD. 
1.2.2 Human research 
Three sources of ordinary, daily life stress frequently have been examined as correlates of health 
outcomes in humans:  work, family, and socioeconomic status (SES).  Given the centrality of 
work and family roles to individuals’ daily lives (Pearlin, 1983), stress encountered in either of 
these 2 domains may be of particular relevance to the development of CVD.  Because of the 
pervasive influence of SES across several life domains, stress associated with socioeconomic 
disadvantage similarly may contribute importantly to CVD risk.  In contrast to the experimental 
work among nonhuman primates, the correlational nature of research on chronic stress and CVD 
among humans precludes the drawing of causal inferences.  However, findings from a number of 
prospective studies suggest that chronic stress derived from occupational, family and 
socioeconomic sources is a reliable antecedent of clinical cardiovascular pathology. 
1.2.2.1 Occupational stress 
A prominent model of occupational stress that frequently has been investigated as a risk factor 
for CVD is the “job strain” construct proposed by Karasek (R.A. Karasek, 1979).  This model 
describes the condition of job strain as resulting from an imbalance of high demand and low 
decision latitude (control) in the workplace (R.A. Karasek, 1979).  In general, 2 methods have 
been used to assess job strain:  self-reports and inference based on job title.  Self-reports, though 
designed to assess objective stressors associated with the work environment (e.g., Does your job 
require you to work hard?), also capture indirectly the stressor appraisal process.  Positive 
endorsement of a given workplace stressor may be influenced both by objective observation of 
the associated environmental stimulus as well as by individuals’ perceptions of that stimulus as 
stressful, particularly if respondents are asked to rate the duration, intensity, or frequency of 
stressor exposure.  By comparison, inference-based measures of occupational stress circumvent 
the influence of individual stressor appraisal by assigning scores on various job characteristics to 
individuals based on their job titles.  Because assigned scores have been derived from pooled 
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survey data, it reasonably can be assumed that the majority of persons who are employed in a 
given occupation would perceive a similar level of job strain.  A major limitation of inference-
based methods, however, concerns intra-occupational variability in job strain (Schwartz, 2000).  
For example, the manager of a small, independent grocery store may be exposed to different 
levels of occupational stress relative to a regional manager of a Fortune 500 company, even 
though both individuals carry the same job title. 
Both self-report and inference-based methods have been incorporated into research on 
job strain and CVD.  A recent review of the literature on workplace environment and CVD risk 
indicated that self-report measures appear to be more reliable predictors of hard CVD endpoints 
than inference-based measures (Belkic et al., 2000).  Among 10 prospective studies reviewed by 
Belkic, 6 reported positive associations between low workplace control, or the combination of 
low control with high demand (job strain) and risk for clinical CVD.  All 6 positive studies 
employed self-report measures of job strain.  By comparison, 3 of the 4 studies that reported 
negligible associations between job strain or its components and risk for CVD employed 
inference-based methods (Belkic et al., 2000).   
It is important to note that Belkic’s review was limited to studies that included only male 
participants.  A comparatively smaller literature has examined the effects of job strain on risk for 
CVD among women.  Results from these studies largely have been mixed.  An earlier review of 
job strain and CVD research included 3 studies that examined both men and women (Schnall et 
al., 1994).  Two of these investigations reported no sex difference in the risk of clinical CVD 
endpoints associated with high job strain, whereas the third study reported a stronger association 
among women2 (Schnall et al., 1994).  More recently, it has been shown that occupational stress 
may not be as important a predictor of CVD outcomes among women relative to men.  For 
example, findings from the Whitehall II cohort indicated that self-reports of neither job strain nor 
workplace control were important predictors of CVD among women (Kuper & Marmot, 2003).  
Similarly, Lee and colleagues reported no effect of job conditions on CVD risk among female 
participants in the Nurses’ Health Study (Lee, Colditz, Berkman, & Kawachi, 2002).    
In addition to the research that has documented a prospective association between 
occupational stress and risk for clinical CVD outcomes, there is some evidence to suggest that 
                                                 
2 It should be noted that the finding of a stronger effect of job strain among women relative to men was reported in 
an unpublished doctoral dissertation. 
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stress in the workplace may be related to progression of subclinical CVD as well.  In one of 2 
known studies to examine occupational stress as a predictor of change in markers of subclinical 
CVD, Lynch and colleagues found that men who reported a combination of high workplace 
demands and low income showed greater progression of carotid atherosclerosis relative to men 
who reported low demands and high income (J. Lynch, Krause, Kaplan, Salonen, & Salonen, 
1997).  Additionally, Everson and colleagues found that the association between work stress and 
carotid artery atherosclerosis progression in this sample was especially marked among men who 
showed high cardiovascular reactivity in anticipation of an exercise task (Everson et al., 1997).    
Summary.  Though not entirely consistent, findings from research on job strain and 
CVD suggest that certain features of the work environment may predispose individuals to risk 
for clinical CVD outcomes.  Specific conclusions based on this literature include the following: 
(1) Self-report measures appear to be more reliable correlates of CVD outcomes than inference-
based measures; (2) men and women may differ on the extent to which occupational stress, 
particularly the low-control dimension of job strain, predicts CVD; and (3) occupational stress 
may influence CVD at early stages in the disease process.  
1.2.2.2 Family stress 
Within the family domain, chronic psychosocial stress may arise from a number of sources.  One 
potential source of chronic stress is the marital relationship.  Because of the enduring nature of 
this social tie and the centrality of the spouse role to many adults’ lives, chronic stress within the 
context of marriage may be of particular relevance to CVD risk.  A second important source of 
chronic stress within the family domain is that which arises as a function of taking on informal 
caregiving responsibilities for a chronically ill spouse or relative.  Results from 2 recent meta-
analyses suggest that caregiver status may be related to higher levels of self-reported stress and 
depression, and a slightly greater risk of physical morbidity (Pinquart & Sorensen, 2003; 
Vitaliano, Zhang, & Scanlan, 2003).  Thus, caregiving may be an additional source of family 
stress that could influence CVD pathogenesis. 
Marital stress.  The extant literature on marriage and health is replete with research on 
marital status and risk for CVD morbidity and mortality, with the married having a protective 
advantage over the unmarried (Kiecolt-Glaser & Newton, 2001).  By comparison, only 3 known 
studies have investigated a prospective relation between marital stress and CVD outcomes 
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(Coyne et al., 2001; Gallo et al., 2003; Orth-Gomer et al., 2000).  In the first 2 studies, high 
marital stress at admission to hospital predicted a greater risk of recurrent CVD events or 
mortality among persons with pre-existing disease (Coyne et al., 2001; Orth-Gomer et al., 2000).  
Orth-Gomer and colleagues followed a sample of 187 married or cohabiting women for 5 years 
following hospitalization for an acute myocardial infarction.  Marital stress was measured with 
the Stockholm Marital Stress Scale (SMSS), a structured interview that was developed by the 
authors.  After controlling for age, baseline CVD severity, use of estrogen, education, and 
traditional biomedical risk factors, women who reported marital stress at baseline were at greater 
risk of experiencing a recurrent event (recurrent MI, CVD mortality, or revascularization 
procedure) relative to women who reported low or no marital stress at baseline (Orth-Gomer et 
al., 2000). 
Coyne and colleagues investigated whether baseline marital stress predicted 4-year 
survival among 189 patients (21% female, 17% non-white) who had been hospitalized for 
congestive heart failure.  Marital stress was assessed with a composite measure that was 
comprised of responses to individual patient and spouse interviews and an observer-coded rating 
of positive behaviors during a videotaped marital problem discussion.  Analyses that adjusted for 
gender and baseline disease severity revealed that more marital stress predicted shorter survival 
time.  Although men and women differed on a number of baseline characteristics, with women 
showing worse functional impairment, a shorter time since diagnosis, and reporting less marital 
stress, gender was not a significant predictor of survival.  Gender did, however, moderate the 
effect of marital stress on survival such that the association was stronger among women relative 
to men (Coyne et al., 2001). 
In the third study, Gallo and colleagues examined changes in carotid artery 
atherosclerosis among healthy, middle-aged women who could be classified into one of the 
following 3 groups: satisfied with marriage; dissatisfied with marriage; or unmarried.  Marital 
satisfaction was assessed with a 7-item self-report measure that was administered at baseline and 
3 years later.  Results indicated that women who were satisfied with their marriages at baseline 
showed the least carotid atherosclerosis progression during the 3 years between the 11- and 14-
year follow-up assessments, whereas women who were not satisfied with their marriages showed 
the greatest progression (Gallo et al., 2003).    
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Caregiver stress.  Like the literature on marital stress and CVD, extant research on 
caregiver stress and CVD-relevant outcomes is sparse.  Despite the research to suggest that 
caregivers have worse health compared to noncaregivers (Vitaliano et al., 2003), only one 
published prospective study has examined whether caregivers have a higher relative risk for 
developing CVD, specifically.  Lee and colleagues examined whether being a caregiver for a 
disabled or ill spouse, parent, or other relative is associated with an elevated risk of incident 
nonfatal or fatal CVD (MI) among participants in the Nurses’ Health Study (Lee, Colditz, 
Berkman, & Kawachi, 2003).  Results indicated that women who reported more than 9 hours per 
week caring for an ill spouse showed an elevated risk of incident CVD relative to non-
caregivers; perceived strain associated with caregiving did not moderate these results.  
Interestingly, CVD risk among women who provided care for ill parents or other relatives did not 
differ from that of women with no caregiving responsibilities (Lee et al., 2003).   
The findings reported by Lee and colleagues suggest that being the primary informal 
caregiver for an ill or disabled spouse may be associated with elevated risk of incident CVD 
among previously healthy middle-aged women.  That the risk associated with caregiver status 
was independent of perceived caregiver strain stands in contrast to findings from an earlier study 
that examined caregiver stress as a predictor of all-cause mortality (Schulz & Beach, 1999).  
Schulz and Beach found that only caregivers who reported experiencing strain associated with 
providing care were at higher risk of mortality relative to non-caregivers; caregivers who 
reported no strain did not differ from non-caregivers in mortality risk.  A number of factors 
might have contributed to the discrepant findings between these 2 studies.  Schulz and Beach 
studied male and female caregivers, whereas the sample employed by Lee and colleagues was 
comprised entirely of women.  Men are less likely than women to act as sole or primary 
caregivers, and more likely than women to receive respite from other informal caregivers or from 
formal care providing services (R. Stone, Cafferata, & Sangl, 1987).  Thus, the inherent 
stressfulness of being a caregiver may be reduced for men relative to women.  In this way, 
caregiver status may represent a different type of stressor for men than it does for women.  That 
the sample employed by Schulz and Beach was not large enough to examine associations by 
cause of death also might explain differences between the 2 studies:  patterns of relations 
between caregiver stress and mortality may differ between all-cause and CVD death.  This 
explanation is unlikely, however, given that CVD is a leading cause of premature mortality 
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(American Heart Association, 2003).  Finally, whereas Lee and colleagues controlled for CVD 
risk factors in their analyses, Schulz and Beach did not make these adjustments.  
Summary.  Findings from the above studies suggest that stressors encountered within the 
family domain may be associated with an elevated risk for cardiovascular morbidity and 
mortality.  Perceptions of marital stress appear to predict worse outcomes among persons with 
pre-existing CVD, and may influence early atherogenesis among women without history of 
clinical cardiovascular pathology.  Stress associated with being an informal family caregiver also 
may influence risk for future CVD.  However, it is unclear whether CVD risk associated with 
caregiving depends upon level of perceived caregiver burden.  The pattern of findings to date 
suggests that stress in the family domain may be a more important contributor to risk for CVD 
among women relative to men.  However, given the paucity of studies that have conducted 
gender comparisons, it has yet to be determined whether this apparent trend is indicative of a true 
sex difference.  
1.2.2.3 Low socioeconomic status (SES) 
In addition to stressors that are encountered within the work and family domains, low 
socioeconomic status (SES) might be conceived of as another type of pervasive psychosocial 
stressor with the capacity to influence risk for developing CVD.  There is a recognized gradient 
of CVD risk associated with SES such that the probability of CVD morbidity and mortality 
increases continuously with decreasing status (G. A. Kaplan & Keil, 1993; Pickering, 1999).  In 
addition to the elevated risk for clinical CVD associated with low SES, there also is evidence to 
suggest that socioeconomic disadvantage may predict progression of subclinical atherosclerosis 
(J. Lynch, Kaplan, Salonen, & Salonen, 1997).  Lynch and colleagues examined whether (a) 
level of education and (b) income each were associated with 4-year progression of carotid artery 
atherosclerosis among male participants in the Kuopio Ischemic Heart Disease Risk Factor Study 
(KIHD).  Results from analyses that were adjusted for age and baseline atherosclerosis indicated 
a significant inverse association between both SES indices and carotid atherosclerosis 
progression (J. Lynch, Kaplan et al., 1997).    
A number of factors may influence the CVD risk associated with low SES both at the 
level of the individual (access to health care, poor health behaviors) and at the level of the 
community (air and water quality, crowding) (Evans & Kantrowitz, 2002).  However, these 
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“physical” factors account for only some of the observed gradient of CVD risk associated with 
socioeconomic disadvantage.  Thus, it is possible that psychological factors, such as perceived 
psychosocial stressors associated with low SES, also may play an important role in determining 
CVD risk (Pickering, 1999).  
1.2.3 Limitations of previous research on chronic stress and CVD 
1.2.3.1 Outcome measures 
As previously discussed, much of the existing prospective research on chronic stress and CVD in 
human populations has focused on clinical endpoints, such as incident or recurrent MI, or 
cardiovascular mortality.  Notable exceptions are the 3 studies that employed progression of 
carotid artery atherosclerosis as the outcome measure (Gallo et al., 2003; J. Lynch, Kaplan et al., 
1997; J. Lynch, Krause et al., 1997).  Findings from studies that employ “hard” CVD endpoints 
are compelling in that they provide suggestive evidence that the experience of psychosocial 
stress might influence individuals’ risk of future clinical CVD.  However, these studies provide 
no information regarding the stage of disease development at which exposure to psychosocial 
stress is likely to influence cardiovascular pathogenesis.  When interest is in examining the role 
of psychosocial stress in earlier stages of the disease process, it may be of benefit to examine 
surrogate endpoints that reflect developing subclinical pathogenesis rather than manifest clinical 
disease. 
1.2.3.2 Characteristics of sample populations    
A second notable limitation of the above reviewed research on psychosocial stress and CVD 
concerns characteristics of the studied populations.  For example, much of the occupational 
stress research has been conducted on male samples, thus limiting the extent to which associated 
findings might be generalized to women.  By comparison, 2 of 3 marital quality studies (Gallo et 
al., 2003; Orth-Gomer et al., 2000) employed entirely female samples.  Given the moderating 
effect of gender reported by Coyne and colleagues (Coyne et al., 2001), it seems it would benefit 
future investigations to include both male and female participants.  Interpretation of the marital 
quality literature also is complicated by the fact that Orth-Gomer and Coyne (Coyne et al., 2001; 
Orth-Gomer et al., 2000) each employed samples with pre-existing disease.  Although both 
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studies controlled for CVD severity, the possibility that some feature of the disease experience 
was influencing participants’ reports of marital quality cannot be excluded.  Thus, the proposed 
direction of causality is called into question. 
1.2.3.3 Lack of emphasis on explanatory mechanisms 
Another limitation of the extant research on psychosocial stress and CVD is the lack of emphasis 
on identifying plausible physiologic mechanisms by which psychosocial stress might be 
translated into observable cardiovascular pathology.  One notable exception is the Gallo study 
(Gallo et al., 2003) wherein findings showed that pulse pressure and serum triglyceride levels 
were partial mediators of the association between marital satisfaction and atherosclerotic 
progression.  Despite the growing speculation that inflammatory processes may mediate the 
association between chronic stress and CVD (Black & Garbutt, 2002), however, no known 
studies have examined this specific explanatory mechanism.  
1.2.4 Summary 
Psychosocial stress frequently has been observed to correlate with risk for clinical CVD 
outcomes.  Chronic stress associated with work, family, and socioeconomic domains may be 
especially relevant to CVD risk.  That chronic or repeated exposure to psychosocial stress might 
be related causally to the initiation and progression of CVD has been suggested by findings from 
comparative research.  It is difficult to draw causal inferences based on the human literature, 
however, due to the employ of correlational designs.  Additional limitations of the above-
reviewed human stress research with regard to understanding the role of stress in early 
cardiovascular pathogenesis include the following: (a) a predominant focus on clinical CVD end 
points; (b) lack of generalizability due to characteristics of the employed sample populations; 
and (c) the lack of emphases on physiological mechanisms. 
  13
1.3 PROPOSED MECHANISMS 
The present study was designed to address some of the acknowledged limitations of the extant 
literature on chronic stress and CVD in human samples.  Specifically, the present study examines 
the role of inflammatory processes in stress-related subclinical CVD pathogenesis among 
persons without known history of CVD.  Before presenting the employed methodology, the 
following pages will examine relevant literatures that make the case for investigating 
inflammation as a mediator in the stress-CVD association.  The discussion will begin with a brief 
overview of the evidence implicating activation of the sympathetic nervous system (SNS) in the 
process of early cardiovascular pathogenesis.  Attention is given to this literature because SNS 
activity is one proximal physiologic mechanism by which psychosocial stress may be linked to 
more distal inflammatory processes. 
1.3.1 Sympathetic nervous system activation and CVD 
Hemodynamic and neuroendocrine changes associated with chronic SNS activation have been 
shown to initiate pathophysiologic processes relevant to CVD risk (Manuck, Kaplan, Muldoon, 
Adams, & Clarkson, 1991; Manuck et al., 1995).  The most compelling evidence for a mediating 
role of SNS activation in the development of CVD has been derived from research conducted 
among nonhuman primates (Kaplan et al., 1987; 1989).  As described above, Kaplan and 
colleagues found that dominant male cynomolgus macaques that were exposed to an unstable 
social environment showed more severe coronary atherosclerosis than macaques not exposed to 
this chronic stressor.  Involvement of SNS activation as a mediator of the relation between stress 
and vascular pathology was suggested by the additional finding that atherogenesis in macaques 
that were placed in unstable social settings was eliminated by administration of a beta-
adrenoreceptor antagonist (J. R. Kaplan & Manuck, 1989; J. R. Kaplan, Manuck, Adams, 
Weingand, & Clarkson, 1987).  These findings are corroborated by results from 3 prominent 
non-primate models that examined the association between chronic exposure to laboratory 
stressors and development of hypertension, an important risk factor for CVD (Henry et al., 1967; 
Julius, Brant, Krause, & Buda, 1989; Lawler, Cox, Sanders, & Mitchell, 1988).  In all 3 of these 
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studies, SNS activation associated with repeated exposure to a psychological stressor predicted 
development of sustained hypertension.  
1.3.2 Inflammation as a mediator between SNS activation and CVD 
The above comparative studies support an association between stressor-induced elevations in 
SNS activity and CVD-relevant outcomes.  Various mechanisms have been proposed to explain 
how SNS activation might be translated into cardiovascular pathology.  These include direct 
effects of catecholamines on vascular smooth muscle synthesis (deBlois et al., 1996), and 
indirect effects via changes in hemoconcentration (Allen & Patterson, 1995), hemostasis (von 
Kanel, Mills, Fainman, & Dimsdale, 2001), platelet activation (Markovitz & Matthews, 1991), 
and blood pressure (Treiber et al., 2003).  Another proposed mechanism involves activation of 
immune and inflammatory processes (Black & Garbutt, 2002).  Given that atherosclerosis 
increasingly has come to be understood as a chronic inflammatory condition (Ross, 1993), it is 
important to examine whether psychosocial stress plays a role in the initiation of inflammatory 
activities that ultimately contribute to atherogenesis.  As the major focus of the present study is 
to examine inflammation as a mediator in the path linking stress and CVD, the evidence for this 
mechanism will be discussed in detail.   
1.3.2.1 CVD as a chronic inflammatory condition 
Ross proposed a “response-to-injury” theory of atherogenesis that involves ongoing interaction 
between “activated” endothelium and circulating immune, inflammatory, and haemostatic factors 
(Ross, 1993).  Proatherogenic changes characteristic of the early stages of this process include 
(1) increased permeability of the endothelium; (2) upregulation of leukocyte adhesion molecules; 
and (3) migration of leukocytes into the artery wall (Ross, 1999).  Monocytes and monocyte-
derived macrophages are present in the endothelium at all stages of atherogenesis, as well as 
helper and cytotoxic T-lymphocytes.  Once activated, these cells release cytokines, proteolytic 
enzymes, and growth factors.  In addition to facilitating the recruitment of additional 
inflammatory cells, these soluble mediators may contribute directly to further endothelial 
damage (Ross, 1999).  Thus, it has been proposed that low-grade elevations in circulating levels 
of these mediators that result from systemic infection or inflammation may contribute to further 
  15
endothelial damage and/or exacerbation of the ongoing local inflammatory response at the artery 
wall (J.  Danesh et al., 1999).     
Converging evidence from histopathologic, epidemiologic, and experimental research has 
suggested that 2 specific markers of inflammation, interleukin-6 (IL-6) and C-reactive protein 
(CRP) may factor importantly in the development of CVD.  IL-6 is a pleiotropic cytokine with a 
broad range of humoral and cellular immune effects associated with inflammation, host defense, 
and tissue injury.  IL-6, like IL-1 and tumor necrosis factor-alpha (TNF-α), has been identified as 
a major pro-inflammatory cytokine, and is produced by endothelial, smooth muscle, and adipose 
cells, as well as by macrophages (Rabin, 1999).  IL-6 also plays an essential role in the initiation 
of the acute phase response (APR), a systemic reaction to bodily infection or injury, that is 
comprised of a number of physiological and behavioral adjustments including fever, 
leukocytosis, hypersomnia, hyperalgesia, anorexia, and depression (Baumann & Gauldie, 1994).  
CRP is a positive acute phase protein that is synthesized and released by the liver during the 
APR.  Though only trace amounts of CRP are detectable in the circulations of healthy adults (< 
1.0 mg/L), CRP concentrations may increase up to 10,000-fold during an acute infection 
(Hirschfield & Pepys, 2003).  Hepatic release of CRP is thought to depend primarily on 
stimulation by circulating IL-6, and the sole determinant of CRP concentration in the circulation 
is its own rate of synthesis.  Accordingly, mild but persistent elevations in CRP concentration 
have been used as an indirect marker of IL-6 activity, and thus of underlying pathogenic 
inflammatory processes (Whicher, Rifai, & Biasucci, 2001).   
Histopathologic identification of IL-6 and CRP in atherosclerotic lesions.  Several 
studies that have examined human and animal atheroma specimens for the presence of IL-6 and 
CRP have demonstrated that both of these markers are detectible in greater quantities in 
atherosclerotic compared to healthy vessels.  A full review of this literature is beyond the scope 
of the present paper.  However, findings from a few selected studies that were conducted with 
human autopsy or surgical specimens are discussed in detail here.   
Seino and colleagues (Seino et al., 1994) compared expression of IL-6 gene transcripts in 
atherosclerotic and non-atherosclerotic artery sections that were obtained from patients 
undergoing surgical revascularization.  Results showed that IL-6 mRNA expression was 
significantly greater in atherosclerotic relative to healthy arteries, specifically in the intimal layer 
of atherosclerotic lesions (Seino et al., 1994).  Rus and colleagues (Rus, Vlaicu, & Niculescu, 
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1996) detected IL-6-specific deposits in the intima of both diseased and healthy aortic, iliac, and 
femoral artery samples.  However, the number of cells expressing IL-6 mRNA was higher in 
areas of increased intimal thickening and in fibrous plaques relative to normal intima and media.  
Moreover, compared to healthy intima, atherosclerotic intima was characterized by larger 
deposits of IL-6 in the extra-cellular connective tissue matrix (Rus et al., 1996).  
Studies that have examined levels of CRP in human coronary artery specimens provide 
further evidence for an association between inflammatory markers and atherosclerosis.  Zhang 
and colleagues (Zhang, Cliff, Schoefl, & Higgins, 1999) used indirect immunofluorescence to 
examine coronary arteries that were resected at autopsy.  Results revealed that grades of CRP 
immunoreactivity correlated positively with intimal thickness and negatively with lumen 
diameter (Zhang et al., 1999).  Torzewski and colleagues (Torzewski et al., 2000) compared CRP 
levels in sequential sections of diseased coronary artery specimens.  CRP was detectible in artery 
sections with evidence of atherosclerotic lesion development, but not in lesion-free sections.  
Moreover, CRP was apparent in lesions that were morphologically less-advanced, whereas 
macrophages were detectible only in comparatively more advanced lesions.  In other words, 
presence of CRP preceded that of macrophage accumulation (Torzewski et al., 2000).   Findings 
from this latter study suggest that CRP may be involved in the migration of macrophages to the 
endothelium, a fundamental step in early atherogenesis.   
Epidemiologic studies of inflammatory markers and CVD risk.  An impressive 
collection of epidemiologic studies have provided evidence for both cross-sectional and 
prospective associations between (a) IL-6 and (b) CRP and clinical cardiovascular endpoints.  
The majority of prospective studies have been conducted among healthy community populations 
without known history of pre-existing CVD.  Findings from these studies are summarized below. 
To date, 8 prospective studies have examined whether circulating IL-6 levels predict 
long-term CVD outcomes among previously healthy adults (Cesari et al., 2003; Harris, Ferrucci, 
Tracy et al., 1999; Jenny et al., 2002; Luc et al., 2003; Pai et al., 2004; Pradhan et al., 2002; 
Ridker, Hennekens, Buring, & Rifai, 2000; Ridker, Rifai, Stampfer, & Hennekens, 2000).  All of 
these studies reported an increasing crude risk of incident fatal or nonfatal CVD with increasing 
levels of IL-6.  With the exception of 2 studies (Pai et al., 2004; Ridker, Hennekens et al., 2000), 
CVD risk associated with IL-6 remained significant even after controlling for the effects of 
demographic variables and conventional biological and behavioral risk factors.  It should be 
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noted that Ridker and colleagues examined a model that incorporated multiple inflammatory 
markers in addition to IL-6 (CRP, serum amyloid A, soluble intercellular adhesion molecule-1, 
homocysteine).  Inclusion of these factors, specifically, accounted for the attenuation to 
nonsignificance of the risk associated with IL-6 (Ridker, Hennekens et al., 2000).     
CRP has gained considerable attention as a potential non-traditional risk factor for CVD 
as well.  Danesh and colleagues recently conducted a meta-analysis of 22 prospective studies that 
examined the association between circulating CRP and risk of incident CVD (J. Danesh et al., 
2004).  Samples largely were drawn from the general population of healthy, middle-aged and 
older adults.  Data analyses from individual studies included controls for demographic variables 
and established CVD risk factors.  Across all 22 studies, a comparison of CVD cases in the top 
versus the bottom third of CRP concentrations resulted in a combined odds ratio of 1.58 (CI = 
1.48, 1.68).  This calculated risk was somewhat smaller than that which was reported in an 
earlier meta-analysis that included only the 11 studies that were published before 2000 (OR = 
1.9) (J. Danesh, Whincup, & Walker, 2000).  The authors attributed the trend toward more 
extreme findings in the earlier studies to positive publication bias.  Nine additional prospective 
studies of CRP and incident CVD were published between January 2003 and December 2004 
(Ballantyne et al., 2004; Cesari et al., 2003; Koenig, Lowel, Baumert, & Meisinger, 2004; Luc et 
al., 2003; Pai et al., 2004; Ridker & Cook, 2004; Rutter, Meigs, Sullivan, D'Agostino, & Wilson, 
2004; St-Pierre et al., 2003; van der Meer et al., 2003).  Consistent with the findings reviewed by 
Danesh (2004), results from all 9 studies indicated a higher relative risk of CVD at higher CRP 
concentrations.    
Experimental support for a causal role for IL-6 and CRP in atherogenesis.  The 
epidemiologic research described above suggests that the appearance of low-grade inflammatory 
activity, as indicated by modest elevations in basal IL-6 and CRP, antedates clinically manifest 
cardiovascular pathology.  However, the correlational nature of epidemiologic studies precludes 
the ability to draw causal inferences from these data.  Compelling evidence in support of a direct 
causal role for IL-6 and CRP in CVD pathogenesis may be derived from experimental research 
findings. 
Comparative research in vivo and in vitro has indicated that IL-6 may have 
proatherogenic effects on aortic endothelium.  For example, addition of murine recombinant IL-6 
in vitro to isolated rat aortic vascular smooth muscle cells (VSMCs) has been associated with 
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accelerated cell growth (Ikeda et al., 1991).  More recently, daily treatment of atherosclerosis-
prone mice with recombinant IL-6 in vivo has been associated with increased lesion size relative 
to non-treated mice (Huber, Sakkinen, Conze, Hardin, & Tracy, 1999).  Finally, in vitro exposure 
of mouse aortic VSMCs to recombinant murine IL-6 has been associated with increased 
expression of angiotensin-II type 1 receptors with subsequent enhanced production of reactive 
oxygen species (ROS) (Wassmann et al., 2004).  Intra- and extracellular production of ROS has 
been found to trigger and exacerbate endothelial dysfunction, which has important implications 
for atherogenesis (Griendling, Sorescu, Lassengue, & Ushio-Fukai, 2000).   
Findings from experimental research have suggested that CRP, as well, may be more than 
a passive marker of inflammatory atherogenesis.  For example, atherosclerosis-prone 
apolipoprotein-E knockout mice that were transgenic for human CRP developed larger aortic 
lesions relative to mice that did not express human CRP, regardless of whether treated with 
turpentine to induce inflammation (Antoni et al., 2004).  Moreover, lesions from transgenic mice 
were found to express higher amounts of vascular cellular adhesion molecule 1 (VCAM-1) 
mRNA and higher amounts of angiotensin-II type 1 receptor mRNA (Antoni et al., 2004).  
Exposure of human saphenous vein VSMCs in culture to recombinant CRP has been associated 
with increased VSMC DNA synthesis, enhanced angiotensin-II type 1 receptor expression, and 
amplification of basal intracellular production of ROS (C.-H. Wang et al., 2003).  Finally, 
incubation of rat aortic VSMCs with human recombinant CRP in vitro has been associated with 
induction of monocyte chemoattractant peptide and nitrogen oxide synthase gene expression 
(Hattori, Matsumura, & Kasai, 2003). 
Results from 2 recently published clinical trials contribute further support for a causal 
association between CRP and CVD (Nissen et al., 2005; Ridker et al., 2005).  The first study, 
which was conducted among persons who had been hospitalized for acute coronary syndromes, 
examined (a) the effects of statin therapy on CRP levels; and (b) whether resultant reductions in 
CRP are associated with a decreased risk of experiencing a recurrent event.  As expected, 
patients who were assigned to statin therapy were less likely to experience recurrent events 
relative to patients who were not taking statins.  Also as expected, treatment with statins 
predicted lower levels of CRP.  Reductions in CRP following statin therapy predicted a lower 
rate of recurrent events, regardless of associated LDL cholesterol levels (Ridker et al., 2005).  
The second study examined the association between reduced CRP subsequent to intensive statin 
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treatment and progression of coronary artery atherosclerosis among patients with 
angiographically documented coronary disease (Nissen et al., 2005).  Intravascular 
ultrasonographic examination over 18 months revealed that reductions in CRP following statin 
treatment were correlated negatively with progression of coronary atherosclerosis during this 
period.  Once again, the association between reduced CRP and less progression was independent 
of the effects of concurrent reductions in LDL cholesterol (Nissen et al., 2005).     
Summary.  Histopathology research has shown that the inflammatory markers, IL-6 and 
CRP, are present in atherosclerotic lesions, thus implicating them in the process of atherogenesis.  
The clinical relevance of these histopathologic findings is suggested by data from epidemiologic 
research which demonstrate a reliable association between these 2 inflammatory markers and 
risk of incident CVD.  Findings for IL-6 appear slightly stronger than analogous results for CRP.  
However, given the comparatively smaller size of the IL-6 literature, it cannot be concluded with 
certainty that IL-6 is a better predictor of CVD outcomes.  Findings from in vitro and in vivo 
experimental research suggest that IL-6 and CRP may be more than passive bystanders in the 
initiation and progression of atherosclerosis.  Outcomes from 2 recent clinical trials provide 
additional evidence to support a causal role for CRP that is independent of the effects associated 
with other known risk factors.   
1.3.2.2 Autonomic activity and inflammation 
The following conclusions might be drawn based on the research discussed thus far:  (1) The 
association between stress and cardiovascular pathogenesis among laboratory animals appears to 
be mediated by activation of the SNS; and (2) inflammatory processes, in particular those that 
are mediated by IL-6 and CRP, play an important role in atherogenesis.  Whether inflammation 
is a plausible mechanism whereby activity of the SNS might be translated into cardiovascular 
pathology depends on whether SNS activation is associated with pro-inflammatory effects3.  
Such effects might be realized via a direct pathway wherein SNS mediators activate beta-
adrenergic receptors that are expressed on the surface of circulating immune cells.  Alternatively, 
                                                 
3 It should be noted that the role of the HPA axis in inflammation is much better understood than the role of the 
SNS.  However, as beta-adrenergic activation has been linked to CVD risk, the primary outcome of the present 
study, the following discussion will focus on the role of SNS activity on inflammatory processes. 
  20
the SNS may influence systemic inflammation indirectly by affecting other immune processes 
that ultimately result in inflammatory effects. 
Direct pathway.  The physiologic response to stress is associated with activation of the 
SNS and the hypothalamic adreno-cortical (HPA) axis.  Early conceptualizations of stress and 
immunity maintained that stressor-induced upregulation of the activity of either of these 2 stress-
response systems resulted in global suppression of immunity.  More recent evidence has 
suggested that the immunologic response to stress is associated with attenuation of some 
components of immunity and enhancement of others.  Paradigmatic of this change in perspective 
is the model of the TH1/TH2 shift.  Briefly, T-helper lymphocytes may be characterized by 
functions associated with promotion of (a) cellular immunity (TH1); or (b) humoral immunity 
(TH2).  It is thought that stress, via activation of the SNS, shifts the balance of TH1 and TH2 
immune activity in favor of the latter.  Given that TH1, but not TH2, lymphocytes express beta-
adrenergic receptors on their cell surfaces, it further has been proposed that the shift to a 
predominantly TH2-mediated immunity is a consequence of selective suppression of TH1 
activity by the SNS (Rabin, 1999).   
As IL-6 is released from lymphocytes that carry out TH2 functions, it might be expected 
that SNS activation is associated with relatively elevated IL-6 production.  Evidence from 
experimental animal research is consistent with this hypothesis.  Szabó and colleagues found that 
IL-6 release in response to stimulation with lipopolysaccharide (LPS) was exacerbated in mice 
that were pretreated with the non-selective beta-receptor agonist, isoproterenol, relative to mice 
that received no agonist (Szabo et al., 1997).  There also is evidence to suggest that 
downregulation of SNS activity is associated with reduced IL-6 production.  In a study that was 
conducted with rats, Huang and colleagues reported that norepinephrine depletion subsequent to 
treatment with 6-hydroxydopamine (6-OHDA) was associated with an attenuated IL-6 response 
to intravenous administration of recombinant human IL-1β, a known stimulus for IL-6 release in 
vivo (Huang, Takaki, & Arimura, 1997).      
In addition to moderating the inflammatory response to an immunogenic stimulus, there 
also is evidence to suggest that SNS activation in the absence of antigenic stimulation may be 
sufficient to elicit IL-6 secretion from tissue-derived as opposed to hematopoietic (T-
lymphocytes, macrophages) sources.  Liao and colleagues found that injection of epinephrine 
into isolated perfused rat liver in vitro was associated with elevated basal IL-6 expression.  
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Moreover, the enhanced IL-6 production was blocked after addition of propranolol (Liao, Keiser, 
Scales, Kunkel, & Kluger, 1995).  In a study of similar design, Gornekiewicz reported that 
addition of catecholamines to human dermal microvascular endothelium in vitro was associated 
with elevated basal IL-6 protein expression.  Once again, this effect was attenuated after addition 
of a beta-receptor antagonist (Gornikiewicz et al., 2000).  There also are several lines of evidence 
to suggest that beta-adrenergic stimulation upregulates the constitutional expression of IL-6 in 
adipose cells derived from mouse (Burysek & Houstek, 1997; Fasshauer, Klein, Lossner, & 
Paschke, 2003) and human (Mohamed-Ali et al., 2001; Path et al., 2001) populations.  Adipose 
tissue is a major source of circulating IL-6 (Mohamed-Ali et al., 1997).  Thus, insofar as IL-6 
may be related causally to atherogenesis, upregulation of the constitutional secretion of IL-6 via 
beta-adrenergic stimulation may contribute substantially to the creation of a systemic 
proatherogenic milieu.    
Given that IL-6 is the major determinant of CRP synthesis and release by the liver, it 
might be inferred that SNS activation influences levels of circulating CRP, indirectly, via 
associated effects on IL-6 production.  To date, there are no known experimental studies that 
have evaluated whether SNS activation directly influences CRP expression, specifically.  
However, indirect support for an association between SNS activation and CRP is provided by a 
few observational studies that were conducted among hospital patients who were receiving beta-
blocker therapy for treatment of CVD (Anzai et al., 2003; Doo et al., 2001; Jenkins, Keevil, 
Hutchinson, & Brooks, 2002; Joynt et al., 2004).  All 4 studies reported an association between 
use of beta-blockers and lower mean CRP concentrations.  Inference based on the results of these 
studies is limited due to the cross-sectional nature of the findings.  However, the observed 
association between reduced adrenergic activity and CRP expression is compelling, and invites 
further exploration with prospective and experimental investigations. 
Indirect pathway.  It has been proposed that systemic infection or inflammation at sites 
distal to the artery wall can generate low-grade elevations in pro-inflammatory cytokines that 
may be sufficient to create pro-atherogenic conditions (J.  Danesh et al., 1999).  Thus, it might be 
proposed that stress could indirectly influence circulating levels of pro-atherogenic substances 
such as IL-6 and CRP by increasing individuals’ susceptibility to infection.  Evidence from 
several lines of research have indicated that exposure to stress is associated with decreases in 
functional immunity, as indicated by proliferative response to mitogen and natural killer cell 
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activity (Herbert & Cohen, 1993).  These cellular-level associations also have been demonstrated 
at the clinical level, with self-reported severe chronic stress being associated with a greater risk 
of developing cold symptoms following experimental inoculation with common cold viruses 
(Cohen et al., 1998).  That stress-associated infectious status might influence inflammatory 
marker levels has been suggested by a recent study that examined the association between vital 
exhaustion and (a) pathogen burden (i.e., the aggregated seropositivity to antibodies for multiple 
common herpes viruses) and (b) pro-inflammatory cytokines (van der Ven et al., 2003).  Results 
showed that healthy men with high vital exhaustion scores evidenced greater pathogen burden 
relative men with low scores.  Moreover, high vital exhaustion in combination with high 
pathogen burden was associated with elevated circulating IL-6 (van der Ven et al., 2003). 
Another hypothesized route by which stress might influence circulating inflammatory 
markers involves the release of endogenous LPS from the gut into systemic circulation (Black & 
Garbutt, 2002).  A substantial proportion of norepinephrine outflow is directed toward the 
mesenteric organs (Aneman et al., 1996).  Moreover, application of norepinephrine to the 
mesenteric artery is associated with significant contractile response (Smyth, Bobalova, Ward, 
Keef, & Mutafova-Yambolieva, 2000).  Intestinal ischemia has been found to enhance 
paracellular permeability of gut epithelium to LPS (Drewe, Beglinger, & Fricker, 2001).  Thus, it 
is possible that stress-associated vasoconstriction of splanchnic vasculature may promote release 
of LPS into the systemic circulation, which then may elicit the release of pro-inflammatory 
cytokines. 
1.4 SUMMARY AND CONCLUSIONS BASED ON PREVIOUS RESEARCH 
The following conclusions can be drawn from the above review of previous research:  (1) 
chronic stress, variously defined, is associated with risk of clinical CVD outcomes; (2) SNS 
activation appears to mediate the association between chronic stress and cardiovascular 
pathology among laboratory animals; (3) the atherogenic component of CVD is an inflammatory 
process; and (4) SNS activation may upregulate certain pro-inflammatory processes relevant to 
the development and progression of atherosclerosis.  Given these data, it seems reasonable to 
propose that chronic stress may be related causally to cardiovascular pathogenesis via a 
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mechanism involving inflammation (see Figure 1).  However, the plausibility of this model as it 
relates specifically to humans depends upon demonstration that (1) chronic stress is associated 
with early stages in the cardiovascular disease process, and (2) chronic stress is associated with 
elevations in inflammatory activity.   
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Figure 1: Proposed mediation model 
 
1.4.1 Potential moderating influences of cardiovascular reactivity 
Though existing research provides suggestive evidence for a link between chronic stress and 
CVD, reported correlations generally are modest at best.  The small size of these statistical 
associations suggests the presence of (a) persons who have not been exposed to chronic stress 
but who nevertheless develop CVD; and (b) persons who have been exposed to chronic stress but 
who fail to develop CVD.  That chronic stress should predict disease outcomes in some persons 
but not others suggests a potential role of moderating influences. 
Cardiovascular reactivity (CVR) to psychological stress is one factor that may moderate 
the association between chronic stress and CVD.  CVR is conceptualized as a trait characteristic, 
and is measured in terms of changes in cardiovascular activity in response to physical or 
psychological stimuli (Manuck, Kamarck, Kasprowicz, & Waldstein, 1993).  A number of 
processes contribute to individual differences in CVR, with activity of the SNS assumed to be 
one of the most influential (Dunlap & Pfeifer, 1989).  Accordingly, it might be inferred that a 
dispositional tendency toward exaggerated CVR may be an indirect marker for underlying 
dysregulation in SNS function.  Thus, insofar as the association between stress and CVD may be 
accounted for, to some extent, by upregulated SNS activity, it follows that the link between stress 
and CVD may be stronger among persons who show high CVR (see Figure 2). 
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Figure 2: Proposed moderation model 
 
CVR may influence the association between chronic stress and CVD at various points 
along the proposed mediated pathway (c.f. Figure 1).  First of all, CVR may moderate the 
association between stress and inflammation (see Figure 3a).  More specifically, given the 
evidence to suggest that beta-adrenergic activity may influence circulating IL-6 and CRP levels 
(see above), it might be expected that the SNS-mediated effects of chronic stress on 
inflammatory marker levels would be exacerbated among persons who tend to show high CVR 
to stress.  Insofar as inflammation contributes causally to atherogenesis, it seems reasonable to 
propose that exacerbations in stress-associated increases in IL-6 and CRP levels may strengthen 
the association between chronic stress and CVD.      
Alternatively, it is possible that CVR influences the pathway linking stress and CVD by 
moderating the association between inflammation and CVD outcomes (see Figure 3b).  This 
moderating effect of CVR might be conferred by stimulating proatherogenic activities associated 
with IL-6 and CRP via a pathophysiologic mechanism involving changes in hemodynamic 
patterns.   Atherosclerotic lesions tend to develop at regions where arterial blood flow becomes 
nonlaminar, such as the outer aspects of vessel bifurcations and curved portions of arteries 
(Frangos, Gahtan, & Sumpio, 1999).  Fluid shear stress, or the frictional force per unit area 
exerted by blood flow on the arterial endothelium, is significantly reduced in these anatomically 
predisposed regions.  Vulnerable regions further are characterized by relative blood flow stasis, 
which contributes to a “recirculation zone” wherein the adjacent luminal surface gains prolonged 
exposure to pro-atherogenic blood constituents such as damaged red blood cells and platelets 
(Markovitz & Matthews, 1991).  Endothelial dysfunction, even in the absence of apparent 
denudation, is sufficient to trigger an inflammatory response (Ross, 1999).  Thus, it is likely that 
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conditions created in these “recirculation zones” promote the recruitment of inflammatory 
mediators, such as IL-6 and CRP.     
The reductions in shear stress that are thought to initiate the above-described processes 
are most apparent during systole; during diastole the comparatively reduced hemodynamic force 
permits reorganization of blood flow in vulnerable regions.  Elevated heart rates, as might be 
observed during periods of increased stress, reduce the proportion of the cardiac cycle that is 
spent in diastole.  Thus, during periods of increased heart rate, lesion-prone regions of the 
arteries are exposed to pathogenic conditions for a larger proportion of the cardiac cycle 
(Markovitz & Matthews, 1991).  If increased heart rate during stress is associated with intra-
arterial conditions with the potential to exacerbate atherogenesis, it might be argued that 
individuals who show dispositionally larger heart rate responses to stress (i.e., high 
cardiovascular reactors) would be at higher risk for CVD (Manuck et al., 1995).   
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Figure 3: CVR as moderator of the association between chronic stress and CVD 
 
In addition to creating pro-inflammatory conditions at vulnerable artery regions, low 
shear stress also may contribute to atherosclerotic lesion development via permissive effects on 
specific inflammatory-proliferative activities associated with certain cytokines (Ni, Hsieh, Chao, 
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& Wang, 2004; Rectenwald, Moldawer, Huber, Seeger, & Ozaki, 2000; Yamawaki, Lehoux, & 
Berk, 2003).  For example, Ni and colleagues found that addition of differing concentrations of 
IL-6 to bovine aortic endothelial cells in culture was associated with a dose-response increase in 
phosphorylation of the STAT3 protein, which had the ultimate effect of increasing endothelial 
cell proliferation.  Exposure of cultured cells to experimentally-induced shear stress, however, 
attenuated this pro-inflammatory effect of IL-6 by approximately 60% (Ni et al., 2004).  
Experimental shear stress also has been found to attenuate the pro-atherogenic effects associated 
with pretreatment of cultured endothelium with the pro-inflammatory cytokines, TNF-α and IL-1 
(Rectenwald et al., 2000; Yamawaki et al., 2003).  Thus, it might be argued that the lack of this 
protective effect of shear stress against the pro-atherogenic activities of inflammatory cytokines 
may contribute further to the site-specific distribution of atherosclerotic lesions.   
To summarize:  (1) Atherosclerotic lesions tend to develop at arterial sites that are subject 
to low shear stress; (2) reduced shear stress results in the generation of pro-inflammatory 
conditions at vulnerable regions of the artery wall; (3) effects associated with reduced shear 
stress are most evident during systole; (4) elevated heart rate is associated with more time spent 
in systole; and (5) exposure to shear stress may suppress the inflammatory-proliferative effects 
associated with IL-6.  Given these findings, it might be expected that individual differences in 
CVR to stress will moderate the association between chronic stress and CVD risk. 
1.5 PRESENT STUDY 
The Pittsburgh Healthy Heart Project (PHHP) is a longitudinal investigation of the effects of 
psychosocial and biological risk factors on subclinical CVD among a healthy, older adult 
community sample.  Features of the larger study that are directly relevant to the questions posed 
here include the following: ultrasound measurement of carotid artery intima-media thickening 
(IMT) and plaque at baseline and 3-year follow-up; baseline serological measures of IL-6 and 
CRP; and laboratory testing for cardiovascular reactivity (CVR).  Also relevant to the present 
study are PHHP participants’ reports of baseline chronic life stress as assessed by the Chronic 
Stress Scale (CSS) (Norris & Uhl, 1993), a self-report questionnaire measure of chronic stress 
across 7 life domains.        
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The primary objective of the present study was to examine whether:  (1) higher levels of 
chronic stress predicted greater changes in carotid artery IMT and plaque; and (2) the association 
between chronic stress and changes in these surrogate CVD endpoints is mediated by low-grade 
inflammatory activity (see Figure 1).  In exploratory analyses, we examined whether these 
associations differed as a function of sex and age.  Given the findings of previous research on job 
strain and CVD risk that suggest that stress at work may be a stronger correlate of CVD risk 
among men relative to women, we expected that the association between the occupational stress 
subscale of the CSS and IMT and plaque progression would be stronger among male relative to 
female participants.  Similarly, as both the marital stress and caregiving stress literatures suggest 
that these family stressors may be especially relevant to CVD risk among women, we expected 
that the 2 family stress subscales of the CSS (marital stress and filial stress; see below) would be 
stronger predictors of IMT and plaque progression among women relative to men.  A secondary 
objective of the present study was to investigate whether individual differences in cardiovascular 
reactivity to stress moderates the association between chronic stress and IMT and plaque 
progression (see Figure 1.2).  Specifically, we expected that the association between stress and 
progression would be stronger among high relative to low reactors. 
1.5.1 Advantages of PHHP data for examining the questions posed here 
1.5.1.1 Healthy, older adult sample 
Recruitment of a healthy sample has the advantage of reducing the confounding influence of 
symptomatic disease on psychosocial assessments.  The employ of an older adult population 
(range: 50 to 70 years) has advantages as well.  Persons in this age range are at comparatively 
high risk of developing clinically manifest CVD.  Thus, found associations between chronic life 
stress and subclinical CVD progression may have important implications for this group in terms 
of the future development of clinical outcomes.   
1.5.1.2 Ultrasound measures of carotid artery IMT and plaque 
Measures of carotid artery IMT and plaque have been identified as independent risk factors for 
symptomatic cardiovascular disease (Kuller et al., 1995).  IMT, for example, has been found to 
be an independent correlate of future myocardial infarction and stroke among older adults 
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(O'Leary et al., 1999).  The ability to evaluate carotid atherosclerosis in healthy persons who are 
at risk for CVD allows for the potential to identify the presence of modifiable risk factors that 
may be amenable to preventive intervention.  Moreover, examination of subclinical disease 
markers among persons without a history of CVD avoids potential confounds of biased reporting 
of chronic stress that may arise when conducting research among patient populations.  For 
example, relative to persons with known disease, PHHP participants’ reports of chronic stress are 
unlikely to be influenced by knowledge of pre-existing disease and measured outcomes are less 
likely to be influenced by medication use.  It should be noted, however, that a small portion of 
the sample began taking blood pressure (17.0%; n = 47) or cholesterol-lowering (18.5%; n = 51) 
medication at some time during the 3 years of follow-up.  Medication use, as well as hormone 
replacement therapy (HRT) among women (49.6% of female participants; n = 68) will be 
examined for their effects on physiologic outcomes, and will be included as covariates in 
relevant analyses if necessary. 
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2.0  METHOD 
2.1 PARTICIPANTS 
Participants were 276, healthy older persons (mean age = 60.5; range = 50.0 to 70.8), who 
represented a subset of PHHP participants.  The PHHP received approval of the institutional 
review board at the University of Pittsburgh, and participants provided written informed consent 
to all procedures.  Recruitment strategies included targeted mailings and media postings in the 
Pittsburgh metropolitan area.  Major inclusion criteria were age (50-70 years) and menopausal 
status (women were required to be peri- or post-menopausal, defined as absence of menstruation 
during the 6 months prior to enrollment).  Individuals were excluded from the larger study if they 
reported a history of CVD or other chronic disease (including diabetic persons who were taking 
insulin), use of antihypertensive or lipid lowering medication, or pre-menopausal status.  Persons 
with screening blood pressures > 180/110, as well as persons with a pattern of excessive alcohol 
consumption (> 5 portions 3 or more times a week) also were excluded from the PHHP. 
Participants from the larger investigation were selected for inclusion in the present study 
if they (a) had completed the self-report measure of chronic stress at baseline (see below); (b) 
provided usable IL-6 or CRP data from the baseline blood draw (see below); and (c) had 
complete data from ultrasound assessment for carotid atherosclerosis.   
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2.2 MEASURES 
2.2.1 Chronic stress 
Chronic stress was assessed with a multidimensional self-report questionnaire that was designed 
by Norris and Uhl for use in their research on mechanisms explaining the development of 
psychopathology following exposure to a natural disaster (Hurricane Hugo) (Norris & Uhl, 
1993).  The choice of the Norris and Uhl chronic stress scale (CSS) largely was influenced by the 
fact that the CSS is one of only a few available comprehensive measures of chronic stress.  The 
27-item CSS is comprised of 7 multi-item subscales:  marital stress (MAR; 3 items); parental 
stress (PAR; 4 items); filial stress (FIL; 4 items; assesses stress that arises from respondents’ 
relationships with their own parents or other older relatives); financial stress (FIN; 4 items); 
occupational stress (OCC; 4 items); ecological stress (ECO; 5 items); and physical stress (PHYS; 
3 items).  Individual CSS items are displayed in Appendix A.  All items are presented following 
the question stem “In the past 6 months, how often…”, and responses are based on the following 
5-point scale: never (0), almost never (1), sometimes (2), fairly often (3), very often (4).  
Subscale scores are computed as the summed ratings of the component items.  In the original 
Norris and Uhl sample, test-retest stability of the CSS over 6 months was .65 for the total scale.  
Subscale retest reliabilities ranged from .65 for the FIN and PHYS subscales, to .63 for the PAR 
subscale, to .58 for the FIL and OCC subscales, to .43 for the MAR subscale (F.H. Norris, 
personal communication, February 9, 2005).  The somewhat modest retest correlations may be 
due in part to the fact that Norris and Uhl conducted these analyses on a sample of recent natural 
disaster victims, whose lives likely were characterized by significant upheaval during the period 
of retest.   
As originally designed, the CSS does not include a “total” score that is summed across 
subscales.  The authors provided no explanation for their choice not to examine the cumulative 
effects of chronic stress across life domains (Norris & Uhl, 1993).  As we were interested in 
examining whether scores on a comprehensive measure of life stress would correlate with IMT 
and plaque progression, we created an aggregate chronic stress score that was computed as the 
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weighted average stress score across all subscales with non-missing data4.  Thus, for the 
purposes of the present study, we operationalized chronic stress in terms of (a) scores on 
individual subscales and (b) the aggregate chronic stress score.  Preliminary analyses indicated 
that the aggregate CSS score, as well as scores on the individual subscales, correlated in 
expected directions with scores on relevant established stress measures (see Appendix B).   
Two features of the CSS contribute to this scale’s being an appropriate tool for assessing 
chronic stress in the present study:  (1) the measurement of chronic stress exposure across 
several life domains; and (2) reference period of previous 6 months.  Use of a multidimensional 
measure of chronic stress may be preferable to unidimensional assessments because focus on a 
single dimension of individuals’ daily experience (e.g., work life) presumes that the chosen 
stressor is either (a) specifically relevant to cardiovascular pathogenesis; or (b) representative of 
individuals’ total stress experience.  Insofar as either of these assumptions is not met, studies of 
psychosocial correlates of CVD that measure stress in only a single life domain may fail to detect 
associations between disease outcomes and stress that occur in other areas of life.  That the CSS 
asks respondents to report on their experience of life stress during the previous 6 months may 
provide a more accurate estimation of individuals’ “typical” chronic stress exposure relative to 
instruments that ask participants to report on a comparatively shorter time period.  Given the 
slowly progressing nature of CVD, it is likely that enduring chronic stress is likely to play a more 
important role in the developing disease process than short-term, and potentially atypical stress.  
2.2.2 Carotid artery IMT and plaque  
Ultrasound images of the carotid arteries were obtained using Toshiba SSA-270A and SSA-
140A scanners (Toshiba American Medical Systems, Tustin, CA).  The use of ultrasound 
technology to examine the carotid arteries has been found to be a valid and reliable method for 
detecting arterial changes that may be indicative of future disease (Salonen & Salonen, 1993; 
Sutton-Tyrrell, Wolfson, Thompson, & Kelsey, 1992) and the noninvasive nature of ultrasound 
scanning makes it an appropriate procedure for use in asymptomatic populations.  Optimal 
images of the first 1.0 cm of the right and left common (CCA) and internal (ICA) carotid 
                                                 
4 The weighted average score was computed by averaging across mean subscale scores divided by the associated 
standard deviations. 
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arteries, as well as all measurable areas of the right and left carotid bifurcations (i.e., the bulb), 
were digitized for a period of 10 seconds for later scoring of IMT and presence of eccentric 
plaque.  An automated edge-detection system (Automated Measurement System (AMS), 
Goteborg University, Gothenburg, Sweden) was used to measure IMT across the carotid artery 
segments described above.  The automated system is preferable to manual methods as it has been 
shown to be associated with less variability in measurements of ultrasound IMT (Wendelhag, 
Liang, Gustavsson, & Wikstrand, 1997).  Overall mean IMT was derived by taking the average 
of the 6 far-wall loci across both right and left carotid arteries.  IMT progression was computed 
as the arithmetic difference between 3-year follow-up and baseline IMT scores. 
Plaque was defined as a visually distinct area of the vessel that protrudes into the lumen 
with a thickness that is at least 50% greater than surrounding area.  Extent of plaque at each 
locus was indicated on a 4-point scale:  0 = no plaque; 1 = one small plaque (< 30% of vessel 
diameter); 2 = one medium plaque (30-50% of vessel diameter or multiple small plaques); and 3 
= one large plaque (>50% of vessel diameter or multiple plaques with at least one medium 
plaque).  Plaque also was described in terms of the number of visible lesions at each of the 6 loci.  
For the purposes of the present study, overall carotid plaque was represented as the total number 
of visible lesions, summed across the 6 loci.  Change in plaque was computed as the arithmetic 
difference between the number of lesions present at 3-year follow-up less the number of lesions 
present at baseline. 
2.2.3 Inflammatory markers 
Blood samples for inflammatory marker assays were sent to the Department of Pathology, 
School of Medicine, at the University of Vermont.  It should be noted that this laboratory was 
responsible for the development of the high-sensitivity assay for CRP, which is the current gold 
standard (Ridker, Hennekens et al., 2000). 
Serum CRP was measured using a particle enhanced immunonephelometric assay (BN II 
nephelometer; Dade Behring).  Polystyrene particles are coated with monoclonal CRP 
antibodies.  In the presence of CRP, the coated particles agglutinate and cause an increase in the 
intensity of scattered light, with the increase in scatter being proportional to the amount of CRP 
in the sample.  Standardization was performed using the WHO CRP reference standard.  The 
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assay range is 0.175 to 1100 mg/L.  Expected values for CRP in normal, healthy individuals are 
≤ 3 mg/L, with the expected normal range being 0.18 to 5.05 ug/mL.  At the University of 
Vermont, intra-assay CVs associated with this method range from 2.3 to 4.4% and inter-assay 
CVs range from 2.1 to 5.7%.   
Serum IL-6 was measured by ultra-sensitive ELISA (R&D Systems, Minneapolis, MN).  
The lower detection limit was <0.10 pg/mL, and the detection range 0.156 to 10.0 pg/mL.  A 
monoclonal anti-IL6 antibody is coated on the plastic support, and a polyclonal anti-IL6 antibody 
is used as the sandwich antibody.  The amount of IL-6 bound is determined by a color reaction.  
At the University of Vermont, this method is associated with a routine CV of 6.3 % (Harris, 
Ferrucci, Russell, & al., 1999).  
CRP and IL-6 assays were performed on samples obtained from the baseline and 3-year 
blood draws.  The present study examined baseline levels of CRP and IL-6 as potential mediators 
of the association between stress and progression of IMT and plaque. 
2.2.4 Cardiovascular reactivity 
Participants were recruited for a 3-hour laboratory testing session.  Five standardized laboratory 
tasks were presented to each of the participants, interspersed with resting baseline periods.  The 
first 4 tasks were computer-based tasks, programmed using QBASIC and administered on an 
IBM 486 PC.  These tasks previously have been used as part of a standardized testing battery, 
and have been found to evoke significant and reliable changes in cardiovascular activity 
(Kamarck et al., 1992).  Tasks were presented in a standardized format and performed without 
verbalization.  Responses were executed by microswitch or miniature manipulandum, which 
required minimal motoric activity.  Thus, potential confounding by physical movement was 
minimized.  A program routine adjusted task difficulty commensurate with performance, 
equating level of challenge for each subject throughout each task (Debski et al., 1991).  The 4 
tasks included a marksmanship task (Target), a visual short-term memory task (Scanning), a 
psychomotor task (Tracking), and a version of the Stroop Color-Word Conflict Test using 
recorded color words as an auditory distractor.  Each task was 9 minutes in duration. 
The fifth task was an evaluated speaking task that involved the preparation and 
presentation of a story under video-recorded conditions.  Participants were presented with 
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written guidelines around which to organize their presentations (participants were instructed to 
defend themselves in traffic court), followed by a 4-minute speech preparation period, and the 
speech itself (4 minutes).  Speech preparation and presentation were scored as separate task 
periods.  Participants were informed that they would be evaluated based upon their poise, 
articulation, and the content of their speech.  This evaluated speaking task has been found to 
elicit moderately reliable cardiovascular responses on retest (Kamarck, Debski, & Manuck, 
2000). 
Baseline periods.  Preceding each laboratory task was a 10-minute resting baseline 
period, during which subjects were presented with a simple standardized display (Jennings, 
Kamarck, Stewart, Eddy, & Johnson, 1992).  
Cardiovascular measures.  During the laboratory session, the following cardiovascular 
measures were collected at rest and during the tasks: (1) Systolic (SBP) and diastolic (DBP) 
blood pressures were collected at 90-second intervals, using an Accutracker DX monitor; (2) 
Continuous measures of heart rate (HR) were assessed using a 2-lead EKG; signals were 
digitized, ensemble-averaged, and scored using operator-assisted software (Debski et al., 1991); 
(3) Impedance cardiography also was collected in the laboratory.  CVR was defined as 
residualized change scores.  For each parameter (SBP, DBP, HR), readings were averaged 
separately across each task and across all resting baselines.  Each task measure was regressed on 
the corresponding baseline measure, and resulting residualized change scores were standardized 
and averaged across tasks to enhance reliability for individual assessments (Kamarck et al., 
1992).   
2.3 PROCEDURE 
2.3.1 Overview 
Figure 4 presents a flow diagram depicting the temporal sequence of procedures followed by 
PHHP participants.  Following informed consent, baseline data collection procedures for the 
larger study involved 10 laboratory sessions that were scheduled over a 5-month period.  These 
sessions included:  a medical screening visit (enrollment); 3 visits involving training and 
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feedback for an initial 3-day ambulatory monitoring period; a visit for cardiovascular reactivity 
testing; a visit for baseline carotid artery ultrasound assessment; a second visit for additional 
ultrasound measures (not reported here); and 3 visits associated with a second 3-day ambulatory 
monitoring interval.  As data from the ambulatory monitoring component of the PHHP are not 
relevant to research questions being addressed by the present study, details of the associated 
procedure will not be described. 
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Figure 4: Procedure timeline 
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2.3.2 Medical screening visit 
Prior to attending the medical screening visit, participants were instructed to fast for 12 hours.  
Following informed consent procedures, participants provided a thorough medical history that 
included a review of past medical conditions such as heart-related problems (high blood 
pressure, congestive heart failure, arrhythmia, heart murmur/valve problem, need for pacemaker, 
and Rose Questionnaire to evaluate angina), stroke/TIA/CVA, epilepsy/seizures, neurological or 
neuromuscular conditions (multiple sclerosis, Parkinson’s disease, Alzheimer’s), diabetes, 
cancer, endocrine, rheumatologic, lung, liver, kidney disease/acute renal failure, HIV/AIDS, 
amputations, allergies, surgeries and any other diseases or medical conditions.  Participants also 
were asked about medication (prescription, non-prescription, hormone replacement therapy and 
aspirin) and vitamin use, and were screened for excessive alcohol use, smoking status, and 
menopausal status.  Family history (1st degree relative) of heart condition, stroke, high blood 
pressure and nervous/emotional condition also were reviewed 
Physical examination included the following:  casual clinic blood pressures; height, 
weight, and caliper measures (body fat); blood glucose finger stick; and blood draw for 
measurement of insulin, cholesterol, triglycerides, catecholamines, and inflammatory proteins 
(interleukin-6, C-reactive protein).  Blood was drawn from the right or left antecubital vein, and 
labeled with PHHP subject ID number, date and time of sample.  Blood samples were stored at 
room temperature for 40 minutes prior to assay. 
  Following the physical exam, participants completed a series of demographic and health 
behavior questionnaires.  Demographic data collected by these questionnaires included the 
following:  participant marital and employment status and spouse employment status (when 
relevant); information about participants’ family ties, such as number of children and 
grandchildren, and number of persons living in the home; and socioeconomic information such 
as annual household income and highest level of educational attainment (participant and spouse).  
Data on health behaviors included use of tobacco and alcohol products, usual physical activity 
and exercise, and sleep habits5.   
                                                 
5 Not an exhaustive list. 
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2.3.3 Data collection for psychosocial variables 
Approximately one month following the baseline medical screening (mean of 35.6 days, range of 
0 to 257 days), participants returned to the laboratory to train for ambulatory monitoring (not 
discussed further), and to complete a battery of psychosocial questionnaires.  These instruments 
included the  Perceived Stress Scale (PSS) (Cohen, Kamarck, & Mermelstein, 1983); the Job 
Content Questionnaire (JCQ) (R.A. Karasek, 1985); the Beck Depression Inventory (BDI) 
(Beck, Ward, Mendelson, Mock, & Erbaugh, 1961); the Beck Anxiety Inventory (BAI) (Beck, 
Epstein, Brown, & Steer, 1988); the NEO Five-Factor Index (NEO FFI) (Costa & McCrae, 
1989); the Cook-Medley Hostility Scale (CMHS) (Cook & Medley, 1954); and the Dyadic 
Adjustment Scale (DAS) (Spanier, 1976).  Individual questionnaire items were presented on a 
computer screen, and a light pen (or keyboard, on occasion) was used to select responses.  
Questionnaires were formatted such that each item required a response before the participant was 
permitted to proceed to the next item.  This procedure ensured that no items were skipped, and 
that participants were unable to change previous responses.   
Additional psychosocial questionnaires were completed when participants returned to the 
lab approximately 4 months later to train for the second ambulatory monitoring period (mean of 
149.3 days after medical screening, range of 72 to 527 days).  These measures included the CSS 
(Norris & Uhl, 1993); the Buss-Perry Aggression Questionnaire (BPAQ) (Buss & Perry, 1992); 
and the Marlowe-Crowne Social Desirability Questionnaire (MCSD) (Crowne & Marlowe, 
1964).  These questionnaires were administered using the computer-based procedure described 
above.   
2.3.4 Cardiovascular reactivity testing 
About 2 months following enrollment (mean of 69 days, range of 12 to 246 days), participants 
attended a 3-3.5-hour testing session for the assessment of cardiovascular reactivity.  Testing was 
conducted in a small sound-attenuated and temperature-controlled chamber wherein participants 
were fitted with instrumentation for psychophysiologic measurement.  Throughout the session, 
participants were seated in a Lumex reclining chair (Grahamfield, Inc., Atlanta, GA, USA), 
locked in the upright position and equipped with head and body bolsters to standardize and 
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maintain posture during the testing sessions.  Task response manipulanda were attached to a tray 
table that was placed across the arms of the chair.  The video monitor for task presentation was 
situated on an adjustable platform immediately in front of the participant.  Audiotaped 
instructions for each baseline and task were presented over a speaker.  Preceding each computer 
task, written instructions and practice trials were presented on the video monitor.  Participants 
were required to meet specific performance criteria during practice trials before they were 
allowed to proceed, and performance feedback was provided at the end of each task.  Order of 
task presentation (Target, Scanning, Tracking, Stroop, Speech Preparation, Speech Presentation) 
was invariant across subjects.   
2.3.5 Carotid artery ultrasound 
About 2.5 months after enrollment (mean of 72 days, range of 14 to 312 days), participants went 
to the ultrasound laboratory for a baseline scan of the carotid arteries.  On an average of about 39 
months post-enrollment, (mean of 1178 days, range of 972 to 1686 days), participants returned 
for a follow-up ultrasound scan and additional medical screening to update risk factor status. 
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3.0  STATISTICAL POWER 
Given the primary aims of the present study, 6 separate analyses were conducted to compute the 
power of the present sample to detect the following:  (1) a significant association between 
chronic stress and 3 year IMT progression; (2) a significant association between chronic stress 
and 3 year change in plaque lesion number; (3) a significant association between chronic stress 
and IL-6; (4) a significant association between chronic stress and CRP; (5) a significant 
moderating influence of CVR on the association between chronic stress and IMT progression; 
and (6) a significant moderating influence of CVR on the association between chronic stress and 
plaque progression. 
Four pieces of information are included in a power analysis:  anticipated effect size, 
desired power, alpha level, and sample size (J. Cohen, 1988).  From any 3 of these variables, the 
fourth variable can be computed.  With regard to the present power analysis, the sample size was 
known (n = 276) and the 2-tailed alpha level was set to p < .05.  Anticipated effect sizes were 
obtained from existing research.  To date, no known studies have examined the CSS as a 
predictor of CVD-relevant outcomes, or of inflammation.  Thus, approximate effect sizes were 
derived from investigations that focused on other psychosocial factors as predictors of (a) IMT 
and or plaque progression, or (b) circulating markers of inflammation.   
Effect sizes for relevant studies were computed from published means and standard 
deviations when available, and then aggregated across related studies into a single, average effect 
as per procedures described by Rosenthal (Rosenthal, 1991).  It should be noted that one study 
did not include standard deviation information, but did provide R2-change values (Gallo et al., 
2003).  In this case, f2 values were derived from R2 data, and then converted to Pearson’s r using 
procedures described by Cohen (J. Cohen, 1988).   Two studies did not provide sufficient data to 
compute effect sizes based on the above procedures (Everson, Kaplan, Goldberg, Salonen, & 
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Salonen, 1997; Paterniti et al., 2001), and thus did not contribute to aggregate effect sizes.6   
Calculated power for the present study to detect significant findings is presented in Table 1.  As 
indicated by the third column of Table 1, the present study is moderately well-powered to detect 
changes in plaque of the magnitude reported here, but may be limited in power to detect effects 
when IMT change is examined as the outcome.  Power to detect significant findings involving 
inflammatory markers is moderate to good.  By comparison, the power to detect a significant 
moderating effect of CVR on the association between chronic stress and IMT and plaque 
progression, respectively, is small. 
 
Table 1: Results of Power Analyses Based on Effect Sizes Reported in Previous Research 
Model Effect Size* 
(Pearson’s r) 
Power 
(n = 276) 
References 
Stress ? Change in mean IMT .11 .47 (Gallo et al., 2003; Julkunen et al., 1994; 
J. Lynch, Kaplan et al., 1997; J. Lynch, 
Krause et al., 1997; Paterniti et al., 2001) 
Stress ? Change in plaque .15 .71 (Gallo et al., 2003; J. Lynch, Kaplan et 
al., 1997; J. Lynch, Krause et al., 1997) 
Stress ? Average IL-6 levels .40 1.00 (Appels et al., 2000; Lutgendorf et al., 
1999; Maes et al., 1999; Sutherland et 
al., 2003; van der Ven et al., 2003) 
Stress ? Average CRP levels .15 .69 (Hapuarachchi et al., 2003; Steptoe & 
Marmot, 2003) 
Stress–by-CVR ? change in mean IMT .06 .17 (J. W. Lynch et al., 1998) 
Stress–by-CVR ? change in plaque .04 .10 (J. W. Lynch et al., 1998) 
 
 
                                                 
6 Paterniti et al. included data sufficient to compute an effect for mean IMT but not for plaque. 
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4.0  DATA ANALYSIS 
4.1 MAIN ANALYSIS 
All statistical analyses were conducted using the SAS statistical software package, (Version 8; 
SAS Institute, Cary, NC).  The GLM procedure in SAS was used to compute main analyses with 
IMT change as the outcome.  Inspection of the carotid plaque data revealed a skewed, kurtotic 
distribution, with the mode and median 3-year change in number of plaque lesions being 0.  
Thus, change in lesion number was converted to a binary variable:  1 = increase in lesion 
number, and 0 = no change or negative change in lesions.  All analyses with plaque change as the 
outcome were computed with the LOGISTIC procedure in SAS.   
Preliminary analyses were conducted to determine which demographic and biobehavioral 
variables should be included in the proposed models as covariates.  Candidate variables included 
the following:  age, sex, race (white vs. non-white), clinic blood pressure (SBP, DBP, and pulse 
pressure7), total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein 
cholesterol (HDL), triglycerides, body mass index (BMI)8, tobacco use, alcohol use, physical 
activity, history of diabetes or rheumatologic conditions, and use of anti-hypertensive, 
cholesterol-lowering, anti-inflammatory (including aspirin), or hormone replacement 
medications during follow-up.  The following procedure was used to determine which of the 
candidate variables would be included as covariates in the final analyses:  First, we conducted 
univariate correlations between the candidate variables and each of the four outcomes of interest 
(IMT change, plaque change, CRP, IL-6).  Next, baseline measures (for IMT and plaque change) 
and any demographic variables that were significantly correlated with a given outcome were 
entered into a regression model to predict that outcome.  Then, individual candidate variables 
                                                 
7 Pulse pressure (PP) = SBP-DBP. 
8 Three-year change in clinic blood pressures, cholesterol fractions, triglycerides and BMI were examined as 
covariates in addition to baseline levels of each of these variables. 
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that were significantly correlated with the outcome in univariate analyses were included with the 
demographic variables and examined as predictors of the outcome.  All variables that remained 
independent predictors of the outcome when examined with baseline IMT or plaque (where 
relevant) and the demographic variables were then entered simultaneously in a single regression 
equation.  If the effect associated with a potential covariate failed to reach significance when 
examined with the other candidate variables in multivariate analyses, then that variable was 
excluded from the final model.    
4.2 POTENTIAL MODERATING EFFECT OF CVR 
We examined the potential moderating effect of CVR on the association between CSS variables 
and cardiovascular outcomes by including, in separate models, interaction terms that consisted of 
(a) average CSS or CSS subscale scores, and (b) systolic, diastolic, or heart rate reactivity, 
respectively.  Significant interaction effects were explored by examining the simple effect of 
stress on IMT or plaque change at one standard deviation above or below the centered mean of 
reactivity, as per the recommendation of Aiken and West (Aiken & West, 1991). 
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5.0  RESULTS 
5.1 SAMPLE CHARACTERISTICS 
 
From the original PHHP sample (n = 464), 376 participants received ultrasound scans of the 
carotid arteries at baseline, with 375 providing usable data.  Of these, 361 received follow-up 
scans, with 359 providing usable data from both baseline and follow-up.  As administration of 
the CSS was initiated after the PHHP was already in progress, only 294 of the participants with 
complete baseline and follow-up ultrasound data also provided data on this measure.  From this 
subsample, 18 participants were excluded due to missing CRP or IL-6 data, thus resulting in the 
present sample of n = 276.  Participants who were administered the CSS did not differ from 
those who were not administered the measure on most risk factor variables, inflammatory marker 
levels, baseline IMT and plaque, and IMT and plaque change.  The 2 groups did differ, however, 
on HDL cholesterol level (present sample lower; t = -3.44, p < .001) and waist-to-hip ratio 
(present sample larger; t = 3.77, p < .001). 
The present sample (n = 276) was 49.6% female, and 17.0% nonwhite.  Participants 
represented all levels of educational attainment, with 26.4% of the sample having completed 
high school or less, and 48.9% having completed a bachelor’s or more advanced degree.  This 
distribution of educational attainment indicates that the sample is, in general, more highly 
educated than the population as a whole.  74.6% of the sample reported being married or having 
a spousal equivalent; 58.3% were employed at least part-time; and 88.0% reported having at least 
one child. 
Table 2 displays descriptive data on baseline risk factors and inflammatory markers for 
the entire sample and separately by sex.  As indicated by the table, the sample was, on average, 
slightly overweight (normal BMI: 18.5-24.9), had slightly elevated SBP (normal SBP:  < 120 
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mmHg), slightly elevated total and LDL cholesterol levels (desirable:  < 200 mg/dL, < 100 
mg/dL, respectively), and slightly low HDL cholesterol levels (desirable:  > 60 mg/dL).  On 
average, triglyceride levels were in the desirable range (< 200 mg/dL), and glucose values were 
normal (< 100 mg/dL).  As participants were excluded from the present report if CRP or IL-6 
values exceeded 10μg/mL and 10pg/mL, respectively, measured values for these 2 inflammatory 
markers were within normal limits.  Distributions of inflammatory markers for the entire sample 
and by sex are displayed in Figures 5-10.  
 
Table 2: Sample descriptive data 
 
Total Sample  
(n = 276) 
Men 
(n = 139) 
Women 
(n = 137) 
Sex Difference 
p
Age 60.5 (5.0)  60.4 (5.3) 60.6 (4.7) .76 
% Female (n) 49.6 (137)  -- -- -- 
% Non-white (n) 16.7 (46) 15.1 (21) 18.3 (25) .48 
% High school or  less (n) 26.5 (73) 16.6 (23) 36.5 (50) < .001 
% Current smokers (n) 10.9 (30) 13.7 (19) 8.0 (11) .13 
BMI 27.9 (4.6) 28.0 (3.5) 27.8 (5.6) .73 
Waist Circum cm 100.6 (11.3) 101.6 (9.9) 99.6 (12.6) .15 
Waist-to-hip ratio .98 (.07) 1.02 (.05) .94 (.07) <.001 
Total Cholesterol mg/dL 213.6 (35.1) 209.4 (31.2) 217.9 (38.3) <.05 
LDL mg/dL 132.7 (32.6) 132.6 (28.1) 132.8 (36.7) .95 
HDL mg/dL 53.2 (15.0) 46.9 (11.7) 59.7 (15.3) <.001 
Triglycerides mg/dL 137.4 (76.6) 147.8 (87.8) 126.9 (61.7) <.02 
Glucose 92.8 (14.9) 95.4 (16.5) 90.3 (12.5) <.01 
SBP mmHg 129.6 (15.7) 129.4 (15.4) 129.8 (15.9) .82 
DBP mmHg 80.0 (9.2) 80.8 (8.6) 79.2 (9.6) .14 
PP mmHg 49.6 (12.6) 48.6 (12.6) 50.7 (12.6) .18 
CRP ug/mL 2.92 (3.3) 2.2 (2.6) 3.6 (3.9) <.001 
IL-6 pg/mL 1.81 (1.3) 1.8 (1.5) 1.8 (1.0) .82 
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Figure 5: Distribution of CRP Concentrations--Entire Sample 
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Figure 6: Distribution of CRP Concentrations—Men 
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Figure 7: Distribution of CRP Concentrations—Women 
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Figure 8: Distribution of IL-6 Concentrations--Entire Sample 
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Figure 9: Distribution of IL-6 Concentrations—Men 
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Figure 10: Distribution of IL-6 Concentrations--Women 
 
Table 3 displays means and standard deviations for average CSS subscale scores for the 
entire sample and by sex.  Men and women differed on reports of occupational and financial 
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stress, with men reporting significantly higher levels of each of these two dimensions of chronic 
stress. 
 
Table 3: Means and Standard Deviations of CSS Scores for Entire Sample and by Sex 
  
Total Sample 
(n = 276) 
 
Men 
(n = 139) 
 
Women 
(n = 137) 
 
Sex Difference 
p
CSS Average 1.24 (.55) 1.29 (.56) 1.19 (.54) .12 
Marital stress 3.52 (2.76) 3.76 (2.43) 3.28 (3.04) .15 
Parental stress 4.91 (3.40) 4.92 (3.31) 4.90 (3.50) .96 
Filial stress 5.87 (4.65) 6.04 (4.40) 5.70 (4.90) .55 
Occupational stress 2.93 (2.78) 3.35 (2.95) 2.51 (2.53) .01 
Financial stress 3.43 (3.05) 4.13 (3.24) 2.74 (2.66) .0001 
Ecological stress 3.51 (3.33) 3.63 (3.35) 3.39 (3.33) .56 
Physical Stress 1.23 (1.66) 1.15 (1.66) 1.31 (1.66) .39 
  
 
Table 4 displays means and standard deviations for average baseline, follow-up and 
change values for IMT.  Distributions of baseline IMT and IMT change scores for the entire 
sample and by sex are displayed in Figures 11 through 16.  Participants showed modest carotid 
intima-media thickening during the 3 years of follow-up, with men showing greater progression 
than women.  Normative data on IMT progression have been collected from the Atherosclerosis 
Risk in Communities (ARIC) study (Chambless et al., 2002).  Average IMT for men and women 
from the present sample are larger than analogous data reported in ARIC (.66-.69 mm and .59-
.63 mm for men and women, respectively).  Annualized progression rates from the present 
sample (.03 mm/yr) also are somewhat larger than those shown in ARIC (.007-.01 mm/yr).  It 
should be noted that ARIC employed a comparatively younger sample (ages 45-64), and 
examined only the common carotid artery (i.e., internal carotid artery and carotid bulb 
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measurements were not included in the ARIC IMT index).  Comparable common carotid data 
from the present sample show an annualized change of .01 mm (men:  .014 mm/yr; women:  .006 
mm/yr), which falls within the upper range of the ARIC data. 
40.6% (n = 112) of the present sample showed evidence of visible plaque at baseline, and 
45.7% (n = 126) showed an increase in the number of plaque lesions from baseline to follow-up.  
The proportion of men and women, respectively, with plaque at baseline did not differ 
significantly (men:  43.2%; women:  38.0%; chi2 = .78, p = .38).  However, a greater proportion 
of men than women showed an increase in lesion number during the follow-up period (men:  
51.8%; women:  39.4%; chi2 = 4.26, p < .05).  Distributions of baseline plaque lesion number 
and change in lesions for the entire sample and by sex are shown in Figures 17 through 22. 
Baseline IMT score was positively correlated with the presence of plaque lesions at 
baseline (r = .46, p < .001).  IMT change was positively correlated with increase in number of 
plaque lesions during the follow-up (r = .31, p < .001). 
 
Table 4: Average baseline, follow-up and change values for IMT 
  
Sample 
(n = 276) 
 
Men 
(n = 139) 
 
Women 
(n = 137) 
 
Sex Difference 
p
Baseline IMT  .77 (.15) .79 (.16) .74 (.14) < .02 
Follow-up IMT  .85 (.22) .91 (.24) .80 (.19) < .001 
IMT Change  .09 (.14) .12 (.16) .05 (.11) < .001 
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Figure 11: Distribution of Baseline IMT Scores—Entire Sample 
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Figure 12:  Distribution of Baseline IMT Scores—Men 
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Figure 13: Distribution of Baseline IMT Scores—Women 
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Figure 14: Distribution of IMT Change Scores—Entire Sample 
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Figure 15: Distribution of IMT Change Scores—Men 
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Figure 16: Distribution of IMT Change Scores—Women 
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Figure 17: Baseline Plaque Lesion Number--Entire Sample 
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Figure 18: Baseline Plaque Lesion Number—Men 
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Figure 19: Baseline Plaque Lesion Number—Women 
  
 
1050
Change in Lesion Number
140
120
100
80
60
40
20
0
Fr
eq
ue
nc
y
 
Figure 20: Change in Plaque Lesion Number--Entire Sample 
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Figure 21: Change in Plaque Lesion Number—Men 
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Figure 22: Change in Plaque Lesion Number--Women 
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5.2 COVARIATE SELECTION 
Table 5 displays results of univariate Pearson correlation analyses of IMT and plaque change 
with potential baseline covariates.  Tables 6 and 7 display results from analyses for men and 
women, respectively.  Correlations of baseline IMT and plaque with candidate variables are 
displayed in Tables 5 through 7 as well.  As indicated by Table 5, sex, HDL, alcohol 
consumption, and prescription pain medication use were significantly related to IMT change, 
with male sex, alcohol, and pain medication being related to greater IMT progression, and higher 
HDL being related to less progression.  IMT change also was positively correlated with baseline 
IMT (r=.15, p<.05).  Significant correlates of plaque change were sex, race, SBP, pulse pressure, 
HDL, and waist circumference.  Male sex, non-Caucasian race, higher SBP, greater pulse 
pressure, and larger waist circumference each were related to increase in plaque lesion number, 
whereas higher HDL was associated with lack of or negative change in lesions.  More baseline 
plaque also was related to greater likelihood of plaque increase over time (r=.22, p<.001).   
When correlations were examined separately by sex, weight-related factors (BMI, waist 
circumference, and insulin resistance) emerged as additional correlates of plaque change among 
men.  Among women, use of pain medication emerged as an additional correlate of both IMT 
and plaque change.  Also among women, LDL rather than HDL correlated with plaque change.    
Although several covariates correlated significantly with IMT and plaque when examined 
in univariate analyses, many failed to reach significance when entered into multivariate 
regression, thus resulting in only a few covariates being included in each of the final models.  
Using the procedure described in the Methods, baseline IMT, age, sex, and the age-by-sex cross-
product9 were selected as covariates for the models predicting IMT change.  By comparison, 
analyses for plaque progression resulted in number of baseline plaque lesions, pulse pressure, 
and HDL being selected as covariates.  Table 8 displays beta coefficients and associated 
significance levels for each of the selected covariates of IMT change.10  Table 9 displays odds 
ratios and corresponding confidence intervals for selected covariates of plaque change.11      
 
                                                 
9 Previous analysis showed that the age-by-sex cross-product was an independent predictor of IMT change. 
10 Covariates for IMT analyses by sex: men = baseline IMT and age; women = baseline IMT, age, pain medication 
11 Covariates for plaque analyses by sex: men = baseline plaque, pp, and BMI; women = baseline plaque, LDL, and 
pain medication 
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Table 5: Pearson Correlations of IMT and Plaque with Candidate Baseline Covariates 
 IMT Plaque 
 Baseline Change Baseline Change 
Age   .25***   .03   .22***   .11† 
Sex (0 = male, 1 = female) -.15* -.22*** -.05 -.12* 
Race (1 = white, 2 = non-white) -.06 -.11† -.05 -.14* 
Education -.05   .02 -.17** -.04 
Systolic Blood Pressure (mmHg)   .13* -.01   .09   .17** 
Diastolic Blood Pressure (mmHg) -.03   .01 -.01   .02 
Pulse Pressure (SBP-DBP)   .18** -.02   .11†   .19** 
Total Cholesterol   .01 -.01   .00   .10† 
LDL   .08   .04   .05   .11† 
HDL -.20** -.14* -.14* -.15* 
Triglycerides   .06   .06   .05   .15* 
Insulin Resistance (log-transformed)   .01   .03   .02   .11† 
Smoking (1 = yes, 2 = no)   .09   .10†   .16**   .03 
Alcohol Use    .09   .14*   .04   .03 
Physical Activity -.04   .06   .02   .06 
BMI    .07   .00   .04   .06 
Waist Circumference   .13*   .01   .09   .14* 
Diabetes Diagnosis    .06   .07   .04   .07 
Rheumatologic Condition   .03   .10   .08 -.05 
Allergies -.06   .08 -.00   .07 
Corticosteroid Drugs for Asthma -.04 -.04 -.09 -.03 
Prescription Pain Medication   .06   .19*   .10   .11† 
Frequency of Aspirin Use -.02 -.09   .04 -.05 
† p < .10.  * p < .05.  ** p < .01.  ***p < .001 
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Table 6: Pearson Correlations of IMT and Plaque with Candidate Baseline Covariates—Men 
 IMT Plaque 
 Baseline Change Baseline Change 
Age .27** .17* .34* .24** 
Race (1 = white, 2 = non-white) -.16† -.15† -.17† -.16† 
Education -.10 -.04 -.20* -.08 
Systolic Blood Pressure (mmHg) .13 -.08 .17* .23** 
Diastolic Blood Pressure (mmHg) -.03 -.04 -.04 .03 
Pulse Pressure (SBP-DBP) .17* -.07 .23** .27** 
Total Cholesterol .01 .01 .09 .07 
LDL .09 .04 -.02 .02 
HDL -.13 -.06 -.11 -.04 
Triglycerides -.02 .01 -.05 .13 
Insulin Resistance (log-transformed) .03 .02 .04 .20* 
Smoking (1 = yes, 2 = no) .02 .04 .16† .01 
Alcohol Use  .07 .07 .08 -.03 
Physical Activity -.16† .05 -.04 .11 
BMI  .10 .05 .11 .19* 
Waist Circumference .11 .04 .14 .20* 
Diabetes Diagnosis  .06 .03 -.01 .06 
Rheumatologic Condition .06 .19* .14† -.05 
Allergies -.03 .15† .03 .18* 
Corticosteroid Drugs for Asthma -.05 -.04 -.11 -.13 
Prescription Pain Medication .08 .13 .07 .03 
Frequency of Aspirin Use -.04 -.15† .01 -.05 
† p < .10.  * p < .05.  ** p < .01.  ***p < .001 
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Table 7: Pearson Correlations of IMT and Plaque with Candidate Baseline Covariates—Women 
 IMT Plaque 
 Baseline Change Baseline Change 
Age .25** .17† .09 -.03 
Race (1 = white, 2 = non-white) .06 -.04 .06 -.11 
Education -.09 -.04 -.19* -.08 
Systolic Blood Pressure (mmHg) .15† .09 .00 .18* 
Diastolic Blood Pressure (mmHg) -.06 .03 -.00 .10 
Pulse Pressure (SBP-DBP) .23** .09 .00 -.01 
Total Cholesterol .05 .04 .09 .14 
LDL .07 .04 .10 .20* 
HDL -.17* -.06 -.16† .17† 
Triglycerides .14 .06 .18* .13 
Insulin Resistance (log-transformed) -.02 .05 .01 .03 
Smoking (1 = yes, 2 = no) .16† .16† .16† .04 
Alcohol Use  -.02 .06 -.06 -.01 
Physical Activity .05 -.01 .07 -.03 
BMI  .05 -.05 -.00 -.04 
Waist Circumference .12 -.06 .04 .08 
Diabetes Diagnosis  .02 .15† .19* .08 
Rheumatologic Condition .01 .02 .02 -.05 
Allergies -.05 .08 -.02 .01 
Corticosteroid Drugs for Asthma -.03 -.06 -.07 .11 
Prescription Pain Medication .04 .31*** .13 .19* 
Frequency of Aspirin Use -.04 -.06 .06 -.08 
Hormone Replacement Therapy -.06 -.05 -.05 -.14 
† p < .10.  * p < .05.  ** p < .01.  ***p < .001 
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Table 8: Results of Multivariate Regression of IMT Change on Selected Covariates 
 
 
 
b
 
t
 
p
Baseline IMT .11 1.92 .06 
Age .01 2.61 .01 
Sex .49 2.43 .02 
Age*Sex -.01 -2.72 .007 
 
 
Table 9: Results of Multivariate Logistic Regression of Plaque Change on Selected Covariates 
 
Stress 
 
Odds Ratio 
 
Confidence Interval 
 
p
Baseline Lesion Number 1.24 1.06, 1.44 .000 
HDL .98 .96, .995 .012 
Pulse Pressure 1.03 1.01, 1.06 .002 
 
 
Tables 10 through 12 display correlations of CRP and IL-6 with the candidate variables 
for the entire sample and separately by sex.  Higher levels of CRP were associated with female 
sex, less education, higher triglyceride levels, greater insulin resistance, greater likelihood of 
being a smoker, less physical activity, greater BMI, larger waist circumference, and use of 
prescription pain medication.  By comparison, higher IL-6 concentrations were associated with 
greater insulin resistance, less physical activity, greater BMI, larger waist circumference, greater 
likelihood of having a rheumatologic condition, and pain medication use. 
When correlations were examined separately by sex, education emerged as a significant 
predictor of IL-6 among men.  Among women, age emerged as a significant correlate of CRP.  
Contrary to what might be expected, older age was associated with lower CRP levels among the 
women in the present sample.    
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Table 10: Pearson Correlations of Inflammatory Markers with Candidate Baseline Covariates 
 CRP IL-6 
Age .12† -.01 
Sex (0 = male, 1 = female) .20** .02 
Race (1 = white, 2 = non-white) .07 .08 
Education -.22*** -.11† 
Systolic Blood Pressure (mmHg) .05 .06 
Diastolic Blood Pressure (mmHg) .09 .11† 
Pulse Pressure (SBP-DBP) -.00 -.01 
Total Cholesterol .12† -.08 
LDL .05 -.11† 
HDL .02 -.09 
Triglycerides .14* .11† 
Insulin Resistance (log-transformed) .20** .21** 
Smoking (1 = yes, 2 = no) .16* .17** 
Alcohol Use  -.01 .04 
Physical Activity -.17** -.12* 
BMI  .33*** .34*** 
Waist Circumference .29*** .29*** 
Diabetes Diagnosis  .05 .00 
Rheumatologic Condition .08 .20** 
Allergies .08 .03 
Corticosteroid Drugs for Asthma -.06 -.05 
Prescription Pain Medication .24*** .16** 
Frequency of Aspirin Use -.03 .03 
† p < .01.  * p < .05.  ** p < .01.  ***p < .001 
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Table 11: Pearson Correlations of Inflammatory Markers with Candidate Baseline Covariates—Men 
 CRP IL-6 
Age -.05 .02 
Race (1 = white, 2 = non-white) .07 .09 
Education -.20* -.19* 
Systolic Blood Pressure (mmHg) .12 .08 
Diastolic Blood Pressure (mmHg) .06 .09 
Pulse Pressure (SBP-DBP) .11 .04 
Total Cholesterol .15† -.09 
LDL .14 -.13 
HDL -.17† -.09 
Triglycerides .13 .09 
Insulin Resistance (log-transformed) .15† .09 
Smoking (1 = yes, 2 = no) .24** .21* 
Alcohol Use  .15† .09 
Physical Activity -.10 -.08 
BMI  .31*** .20* 
Waist Circumference .29** .17* 
Diabetes Diagnosis  .08 -.02 
Rheumatologic Condition .19* .33*** 
Allergies .03 .07 
Corticosteroid Drugs for Asthma -.13 -.07 
Prescription Pain Medication .32*** .24** 
Frequency of Aspirin Use .02 .05 
† p < .01.  * p < .05.  ** p < .01.  ***p < .001 
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Table 12: Pearson Correlations of Inflammatory Markers with Candidate Baseline Covariates-Women 
 CRP IL-6 
Age -.23** -.05 
Race (1 = white, 2 = non-white) .06 .07 
Education -.16† -.01 
Systolic Blood Pressure (mmHg) -.03 .04 
Diastolic Blood Pressure (mmHg) .15† .14 
Pulse Pressure (SBP-DBP) -.15 -.06 
Total Cholesterol .05 -.08 
LDL -.03 -.09 
HDL -.02 -.12 
Triglycerides .25** .16† 
Insulin Resistance (log-transformed) .28** .33*** 
Smoking (1 = yes, 2 = no) .11 .12 
Alcohol Use  -.02 -.00 
Physical Activity -.19* -.18* 
BMI  .40*** .48*** 
Waist Circumference .36*** .42*** 
Diabetes Diagnosis  .10 .12 
Rheumatologic Condition -.02 .06 
Allergies .06 -.03 
Corticosteroid Drugs for Asthma .04 -.02 
Prescription Pain Medication .16† .07 
Frequency of Aspirin Use -.06 .01 
Hormone Replacement Therapy .08 -.19* 
† p < .01.  * p < .05.  ** p < .01.  ***p < .001 
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Covariate selection analyses identified sex, baseline BMI, baseline triglyceride levels, 
baseline tobacco use and baseline use of prescription-strength analgesic drugs as variables that 
should be included in analyses to predict CRP in the entire sample.  By comparison, baseline 
BMI, rheumatologic conditions, and tobacco use were selected as covariates for IL-6 analyses.  
Beta coefficients and associated significance levels for each of the selected covariates of CRP 
and IL-6 are displayed in Tables 13 and 14, respectively.12 13   
 
Table 13: Results of Multivariate Regression of CRP Concentration on Selected Covariates 
 
Stress 
 
b
 
t
 
p
Sex .13 4.75 <.001 
BMI .02 2.61 <.001 
Triglycerides .12 2.11 .04 
Tobacco Use .15 3.49 .001 
Prescription Pain Med. .19 2.91 .004 
 
Table 14: Results of Multivariate Regression of IL-6 Concentration on Selected Covariates 
 
Stress 
 
b
 
t
 
p
BMI .01 6.09 <.001 
Rheumatologic Cond. .11 2.94 .004 
Tobacco Use .08 3.39 .001 
 
Because of the important effects of age on IMT, plaque, and inflammatory markers, all 
correlations involving these measures and potential covariates were re-run with additional 
control for age (data not shown).  Results of these partial correlations did not differ to any 
notable extent from the univariate results reported here. 
                                                 
12 Covariates for CRP analyses by sex: men =BMI, smoking, pain medication; women = age, BMI, triglycerides. 
13 Covariates for IL-6 analyses by sex: men = BMI, smoking, rheumatologic condition; women = BMI. 
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5.3 MAIN ANALYSES 
5.3.1 CSS as a predictor of 3-year change in IMT and plaque 
Table 15 displays univariate correlations between CSS subscale scores and measures of carotid 
artery IMT and plaque.  As shown in the table, neither the average CSS score nor any of the 
individual subscales were correlated with baseline IMT, baseline plaque, or plaque change.  
However, marital stress showed a significant inverse correlation with IMT change such that 
reports of higher marital stress were associated with less IMT progression.  Visual inspection of 
IMT change by quintile of marital stress score revealed that the significant negative correlation 
appeared to be due primarily to comparatively low IMT change among participants whose 
marital stress scores were in the highest quintile and comparatively high IMT change among 
participants in the second lowest quintile.  By comparison, a smooth but subtle increase in IMT 
change can be seen with increasing levels of physical stress (see Appendix C). 
 
Table 15: Pearson correlations between CSS scores and carotid artery measures 
  
Baseline IMT 
 
IMT Change 
 
Baseline Plaque 
 
Plaque Change 
Average CSS -.05 .05  -.01     -.04 
Marital -.08   -.16* -.07 -.02 
Parental   -.12† -.06 -.05 -.06 
Filial -.05 -.01 -.07 -.03 
Occupational -.02 .10 -.05 -.09 
Ecological -.03 .05 .04 -.06 
Financial .02 .08 -.03 -.02 
Physical -.01   .11† .10 -.01 
* < .05.  † < .10.       
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Table 16 displays results from multivariate linear regression analyses with IMT change as 
the criterion variable.  After controlling for baseline IMT, age, sex, and the age-by-sex 
interaction, the association between marital stress and 3-year IMT change failed to achieve 
statistical significance.  By comparison, addition of the above covariates resulted in the 
emergence of physical stress as an independent predictor of IMT change, such that higher levels 
of physical stress were associated with greater progression.  No other associations were 
significant. 
 
Table 16: CSS as predictor of 3-year IMT change* 
 
Stress 
 
b
 
t
 
p
Average CSS .01 .84   .40 
Marital -.007 -1.91 .06 
Parental -.001 -.49 .63 
Filial -.0001 -.08 .94 
Occupational .003 1.09 .28 
Ecological .002  1.02 .31 
Financial .002 .84 .40 
Physical .02 2.13 .03 
*Includes controls for baseline IMT, age, sex, age-by-sex 
 
Table 17 displays results from multivariate logistic regression analyses with change in 
plaque as the criterion variable.  Additional statistical control for significant covariates (number 
of plaque lesions at baseline, HDL cholesterol, and pulse pressure) did not reveal any significant 
associations between chronic stress and 3-year plaque change. 
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Table 17: CSS as predictor of 3-year plaque change 
 
Stress 
 
Odds Ratio 
 
Confidence Interval 
 
p
Average CSS .88 .55, 1.39 .58 
Marital 1.02 .90, 1.14 .80 
Parental .97 .89, 1.06 .50 
Filial 1.00 .95, 1.06 .97 
Occupational .93 .82, 1.05 .24 
Ecological .97 .90, 1.05 .41 
Financial .97 .90, 1.06 .51 
Physical 1.02 .88, 1.18 .81 
*Includes controls for baseline plaque, HDL cholesterol, pulse pressure 
5.3.2 Inflammatory markers as predictors of IMT and plaque change 
Table 18 displays univariate correlations between the 2 measured inflammatory markers (CRP, 
IL-6), and measures of carotid artery IMT and plaque.  As indicated by the table, neither 
inflammatory marker was related to baseline or change variables.  In multivariate analyses that 
controlled for baseline IMT, age, sex, and the interaction of age with sex, neither CRP nor IL-6 
emerged as a significant predictor of 3-year IMT change (CRP:  b = -.03, t = -1.07, p = .29.  IL-
6:  b = -.001, t = -.01, p = .99).  Similarly, in multivariate logistic regression analyses that 
controlled for baseline lesion number, HDL cholesterol, and pulse pressure, CRP failed to 
emerge as a significant predictor of 3-year change in plaque (OR = .84, CI = .29, 2.48).  By 
comparison, IL-6 did emerge as an independent predictor of plaque change, but in a direction 
that was opposite to that which was predicted with higher levels of IL-6 being associated with a 
decreased likelihood of plaque progression during the follow-up period (OR = .10, CI = .01, .80).   
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Table 18: Correlations between inflammatory markers and carotid artery measures 
  
Baseline IMT 
 
IMT Change 
 
Baseline Plaque 
 
Plaque Change 
CRP .04 -.07 .03  -.01 
IL-6 .003 .001 .08 -.10 
* < .05.  † < .10.   
 
5.3.3 CSS as predictor of baseline inflammatory marker levels 
Table 19 displays univariate correlations between CSS subscales and each of the measured 
inflammatory markers.  As shown in the table, only the physical stress subscale was significantly 
correlated with CRP, such that higher levels of stress were associated with higher CRP levels.  
None of the CSS subscales were significantly correlated with levels of IL-6. Visual inspection of 
CRP levels by zero, low, middle, and high physical stress groups reveals an apparently linear 
increase in CRP levels with increasing physical stress (see Appendix D). 
Tables 20 and 21 display results from multivariate regression analyses for CRP and IL-6, 
respectively.  After controlling for sex, BMI, triglycerides, smoking status, and use of 
prescription pain medications, physical stress failed to emerge as an independent predictor of 
CRP.  Further analysis indicated that BMI and anti-inflammatory medication use each 
independently accounted for the majority of the reduction in effect associated with physical 
stress.  None of the remaining CSS subscales emerged as significant predictors of either CRP or 
IL-6. 
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Table 19: Correlations between CSS scores and inflammatory markers 
 
Stress 
 
CRP 
 
IL-6 
Average CSS   .11† .05 
Marital .09 .07 
Parental .02 -.08 
Filial -.01 -.01 
Occupational -.04 .01 
Ecological .10 .07 
Financial .05 .06 
Physical  .14*   .10†
* < .05.  † < .10.   
 
Table 20: CSS as predictor of baseline CRP* 
 
Stress 
 
b
 
T
 
p
Average CSS   .019 .79                  .43 
Marital .005 .87 .39 
Parental -.002 -.49 .62 
Filial .002 .60 .55 
Occupational -.005 -.75 .45 
Ecological .003 .76 .45 
Financial .003 .72 .47 
Physical .0005 .05 .96 
* Includes controls for sex, BMI, triglycerides, smoking status, use of prescription pain medication 
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Table 21: CSS as predictor of baseline IL-6* 
 
Stress 
 
b
 
t
 
p
Average CSS -.002 -.13 .90 
Marital .001 .22 .83 
Parental -.003 -1.26 .21 
Filial .001 .56 .58 
Occupational  -.001 -.35 .73 
Ecological .001 .61 .54 
Financial .0003 .13 .90 
Physical -.0002 -.04 .97 
* Includes controls for BMI, current rheumatologic condition, smoking status 
5.3.4 Examination of mediation model 
The primary aim of the present study was to examine whether inflammatory marker levels 
mediate the association between chronic stress and progression of carotid artery IMT and plaque.  
As indicated above, the only positive predictive association between stress and the outcome 
variables was that reported for physical stress and IMT change.  However, neither CRP nor IL-6 
predicted change in IMT.  Moreover, none of the CSS variables were independently related to 
CRP or IL-6.  Thus, it would be of little benefit to test the proposed mediation model.   
5.3.5 CVR as moderator of the association between chronic stress and IMT and plaque 
change 
Although the majority of CSS variables were unrelated to change in IMT or plaque in the entire 
sample, it remains possible that stress may yet be a significant predictor of the these 2 outcomes 
among persons who show higher CVR.  In other words, even though the main effects of most 
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CSS subscales were not significant, the interactive effect of stress with CVR may be.  Tables 22 
through 24 display results of analyses that examined interactions of stress with systolic, diastolic, 
or heart rate reactivity as predictors of change in IMT; Tables 23 through 25 display results of 
analogous analyses that were conducted for change in plaque.  Neither systolic nor heart rate 
reactivity appeared to moderate the association between stress and IMT change.  However, as 
indicated by Table 23, diastolic reactivity emerged as a significant moderator of the association 
between filial stress and change in IMT.  We explored this interaction effect by examining the 
association between filial stress and IMT at one standard deviation above and below the centered 
mean of diastolic reactivity.  Results showed that the direction of association between filial stress 
and IMT differed depending on whether assessed among those exhibiting high or low diastolic 
reactivity.  Specifically, more filial stress was associated with less IMT change when examined 
at high reactivity and with greater IMT change when examined at low reactivity.  In neither 
analysis, however, did the effect of filial stress achieve statistical significance (high reactivity:  b 
= -.003, t = -1.56, p = .12; low reactivity:  b = .003, t = 1.39, p = .17).  In no instance was CVR a 
significant moderator of the effect of stress on plaque change.   
 
Table 22: CSS-by-systolic reactivity on IMT change* 
 
Stress 
 
b
 
t
 
p
Average CSS x CVRsystolic  -.007 -.44  .66 
Marital x CVRsystolic -.002 -.36 .72 
Parental x CVRsystolic .001 .51 .61 
Filial x CVRsystolic .0001 .05 .96 
Occupational x CVRsystolic .0003 .08 .94 
Ecological x CVRsystolic -.0005 -.19 .85 
Financial x CVRsystolic -.001 -.39 .70 
Physical x CVRsystolic -.0007 -.13 .90 
* Includes controls for baseline IMT, age, sex, age-by-sex 
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Table 23: CSS-by-diastolic reactivity on IMT change* 
 
Stress 
 
b
 
t
 
p
Average CSS x CVRdiastolic -.02 -1.06 .29 
Marital x CVRdiastolic .0007 .12 .91 
Parental x CVRdiastolic -.003 -.87 .39 
Filial x CVRdiastolic -.005 -2.11 .04 
Occupational x CVRdiastolic -.0005 -.11 .91 
Ecological x CVRdiastolic -.002 -.58 .57 
Financial x CVRdiastolic -.0003 -.07 .95 
Physical x CVRdiastolic -.0001 -.02 .98 
* Includes controls for baseline IMT, age, sex, age-by-sex 
 
Table 24: CSS-by-heart rate reactivity on IMT change 
 
Stress  
 
b
 
t
 
p
 
Average CSS x CVRheart rate
 
-.01 
 
-.91 
 
.36 
Marital x CVRheart rate .002 .53 .60 
Parental x CVRheart rate -.0009 -.30 .76 
Filial x CVRheart rate -.005 -.26 .79 
Occupational x CVRheart rate .003 .61 .55 
Ecological x CVRheart rate -.002 -.66 .51 
Financial x CVRheart rate -.004 -1.20 .23 
Physical x CVRheart rate  -.002 -.43 .67 
* Includes controls for baseline IMT, age, sex, age-by-sex 
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Table 25: CSS-by-systolic reactivity on plaque change* 
 
Stress 
 
B 
 
S.E. 
 
Wald Chi-Square 
 
Sig. 
Average CSS x CVRsystolic -.23 .29 .61 .43 
Marital x CVRsystolic -.05 .08 .44 .51 
Parental x CVRsystolic -.04 .05 .71 .40 
Filial x CVRsystolic .04 .04 1.02 .31 
Occupational x CVRsystolic -.02 .08 .03 .85 
Ecological x CVRsystolic -.05 .05 .95 .33 
Financial x CVRsystolic .03 .06 .21 .65 
Physical x CVRsystolic -.15 .10 2.24 .13 
*Includes controls for baseline plaque, HDL cholesterol, pulse pressure 
 
Table 26: CSS-by-diastolic reactivity as predictor of 3-year plaque change* 
 
Stress 
 
B 
 
S.E. 
 
Wald Chi-Square 
 
Sig. 
Average CSS x CVRdiastolic -.20 .32 .37 .54 
Marital x CVRdiastolic -.05 .10 .25 .62 
Parental x CVRdiastolic -.09 .06 2.36 .12 
Filial x CVRdiastolic .003 .04 .008 .93 
Occupational x CVRdiastolic -.02 .08 .09 .76 
Ecological x CVRdiastolic -.06 .06 1.28 .26 
Financial x CVRdiastolic .05 .07 .45 .50 
Physical x CVRdiastolic -.01 .12 .01 .91 
* Includes controls for baseline plaque, HDL cholesterol, pulse pressure 
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Table 27: CSS-by-heart rate reactivity as predictor of 3-year plaque change* 
 
Stress 
 
B 
 
S.E. 
 
Wald Chi-Square 
 
Sig. 
Average CSS x CVRheart rate -.02 .29 .003 .96 
Marital x CVRheart rate -.007 .08 .008 .93 
Parental x CVRheart rate .03 .05 .22 .64 
Filial x CVRheart rate .001 .04 .0004 .98 
Occupational x CVRheart rate -.02 .09 .08 .78 
Ecological x CVRheart rate .06 .05 1.18 .28 
Financial x CVRheart rate -.005 .06 .006 .94 
Physical x CVRheart rate -.17 .11 2.51 .11 
* Includes controls for baseline plaque, HDL cholesterol, pulse pressure 
5.4 EXPLORATORY ANALYSES 
5.4.1 Moderating effects of sex and age 
In exploratory analyses, we investigated whether the present study hypotheses might be 
supported if examined separately (a) by sex; and (b) among older and younger participants.  We 
explored the effects of sex and age first by examining each as a moderating variable (i.e., 
included interaction terms involving (a) stress and (b) sex or age, respectively).14   
5.4.1.1 Moderating effects of sex 
Tables 28 and 29 display results from analyses that examined whether sex moderated the 
association between stress and IMT and plaque progression, respectively.  As shown in the 
                                                 
14 Results of sex-stratified analyses are presented in Appendix E. 
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tables, none of the CSS-by-sex interactions emerged as significant effects for either 
cardiovascular outcome measure. 
 
Table 28: CSS-by-sex as predictor of 3-year IMT change* 
 
Stress 
 
b
 
t
 
p
Average CSS x Sex -.03 -1.17 .24 
Marital x Sex -.003 -.44 .66 
Parental x Sex -.004 -.75 .45 
Filial x Sex -.004 -1.42 .16 
Occupational x Sex -.004 -.58 .56 
Ecological x Sex -.006 -1.37 .17 
Financial x Sex .006 1.18 .24 
Physical x Sex -.008 -.92 .36 
* Includes controls for baseline IMT, age 
 
Table 29: CSS-by-sex as predictor of 3-year plaque change* 
 
Stress 
 
Odds Ratio 
 
Confidence Interval 
 
p
Average CSS x Sex 1.58 .62, 4.02 .33 
Marital x Sex 1.18 .93, 1.51 .18 
Parental x Sex 1.04 .88, 1.23 .68 
Filial x Sex 1.02 .92, 1.14 .69 
Occupational x Sex .93 .72, 1.19 .55 
Ecological x Sex 1.04 .89, 1.21 .62 
Financial x Sex 1.15 .97, 1.37 .12 
Physical x Sex 1.02 .76, 1.38 .88 
* Includes controls for baseline plaque, HDL cholesterol, pulse pressure 
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Tables 30 and 31 display results from analyses that examined whether sex moderated the 
association between stress and CRP and IL-6, respectively.  Inspection of Table 30 reveals a 
significant moderating effect of sex on the relation between financial stress and CRP.  We 
explored the significant financial stress-by-sex interaction by examining the simple effect of 
financial stress on CRP in separate models for men and women.  Results for men showed a 
nonsignificant trend for greater financial stress to be associated with higher levels of CRP (b = 
.01, t = 1.82, p = .07).  Among women, financial stress was unrelated to CRP levels (b = -.01, t = 
-.80, p = .43).  No other stress-by-sex effects were significant when CRP was examined as the 
outcome.   
 
Table 30: CSS-by-sex as predictor of baseline CRP 
 
Stress 
 
b
 
t
 
P
Average CSS x Sex .01 .21 .83 
Marital x Sex -.01 -.53 .59 
Parental x Sex .01 1.37 .17 
Filial x Sex .01 1.46 .15 
Occupational x Sex .01 .90 .37 
Ecological x Sex -.00 -.00 .99 
Financial x Sex -.02 -2.12 .04 
Physical x Sex -.01 -.87 .39 
* Includes controls for sex, BMI, triglycerides, smoking status, use of prescription pain medication 
 
Inspection of Table 31 reveals a significant moderating effect of sex on the relation 
between parental stress and IL-6.  Examination of the simple effect for men showed a significant 
inverse association between parental stress and IL-6, such that greater parental stress was 
associated with lower levels of IL-6 (b = -.01, t = -2.09, p < .05).  By comparison, parental stress 
was unrelated to IL-6 levels in women (b = .002, t = 0.68, p = .50).  No other stress-by-sex 
effects were significant when IL-6 was examined as the outcome.   
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Table 31: CSS-by-sex as predictor of baseline IL-6* 
 
Stress 
 
b
 
t
 
p
Average CSS x Sex     .01 .19 .85 
Marital x Sex .01 2.52 .13 
Parental x Sex .01 2.24 .03 
Filial x Sex -.0001 -.03 .98 
Occupational x Sex -.01 -1.20 .23 
Ecological x Sex -.0001 -.04 .97 
Financial x Sex -.0005 -.28 .78 
Physical x Sex -.01 -1.15 .25 
* Includes controls for BMI, current rheumatologic condition, smoking status 
5.4.1.2 Moderating effects of age 
Tables 32 and 33 display results from analyses that examined whether age moderated the 
association between stress and IMT and plaque progression, respectively.  As shown in the 
tables, none of the CSS-by-age interactions emerged as significant effects for either 
cardiovascular outcome measure.    
Tables 34 and 35 display results from analyses that examined whether age moderated the 
association between stress and CRP and IL-6, respectively.  Inspection of Table 34 reveals 
significant moderating effects of age on the relation between 2 of the CSS subscales and levels of 
CRP:  filial stress and occupational stress.  We explored these significant interaction effects by 
examining the respective effects of these 2 stress domains at one standard deviation above and 
below the mean age of the sample (60.5 years).  As might be expected, more filial stress was 
associated with higher levels of CRP among older participants (b = .01, t = 2.75, p < .01).  
Unexpectedly, filial stress was associated with lower CRP levels among younger participants (b 
= -.02, t = -2.45, p < .05).  By comparison, the simple effect of occupational stress on CRP levels 
did not reach significance when examined among older participants (b = .01, t = 1.07, p = .29).  
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Among younger participants, however, occupational stress was associated with lower CRP levels 
(b = -.02, t = -1.98, p < .05).   
Inspection of Table 35 reveals a significant moderating effect of age on the association 
between parental stress and levels of IL-6.  Analysis of simple effects revealed a significant 
inverse association between parental stress and IL-6 among younger participants such that more 
parental stress was associated with lower IL-6 levels (b = -.01, t = -2.54, p < .05).  Among older 
participants, parental stress was unrelated to IL-6 (b = .003, t = .76, p = .45).  No other stress-by-
age interaction effects reached significance. 
Because both sex and age appeared to moderate the effect of parental stress on IL-6, we 
explored the sex-by-age-by-parental stress 3-way interaction.  This complex interaction was not 
significant (b = .0001, t = .11, p = .91).  However, when analyses were conducted separately by 
sex, the moderating effect of age was significant only among the men (men: b= -.009, t = -2.25, p 
< .05; women: b = .003, t = 0.84, p = .40).  Examination of simple slopes revealed that more 
parental stress was associated with lower IL-6 levels among younger men (b = -.02, t = -3.04, p < 
.01).  Among older men, parental stress was unrelated to IL-6 (b = -.001, t = -.29, p =.77). 
 
Table 32: CSS-by-age as predictor of 3-year IMT change* 
 
Stress 
 
b
 
t
 
p
Average CSS x Age .002 .63 .53 
Marital x Age -.0002 -.22 .82 
Parental x Age .0003 .53 .60 
Filial x Age -.00003 -.09 .93 
Occupational x Age .0002 .26 .79 
Ecological x Age -.00001 -.04 .97 
Financial x Age -.0002 -.41 .68 
Physical x Age -001 1.41 .16 
* Includes controls for baseline IMT, sex 
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Table 33: CSS-by-age on 3-year plaque change 
 
Stress 
 
Odds Ratio 
 
Confidence Interval 
 
p
Average CSS x Age .98 .90, 1.08 .71 
Marital x Age .99 .97, 1.01 .40 
Parental x Age .99 .97, 1.00 .12 
Filial x Age 1.00  .98, 1.01 .38 
Occupational x Age .99 .96, 1.02 .52 
Ecological x Age 1.00 .99, 1.02 .63 
Financial x Age 1.01 .99, 1.02 .52 
Physical x Age 1.01 .98, 1.04 .51 
* Includes controls for baseline plaque, HDL cholesterol, pulse pressure 
 
Table 34: CSS-by-age as predictor of baseline CRP* 
 
Stress 
 
b
 
t
 
p
Average CSS x Age   .01 1.64   .10 
Marital x Age .0004 .32 .75 
Parental x Age .001 1.16 .25 
Filial x Age .002   3.71 < .001 
Occupational x Age .003 2.08 .04 
Ecological x Age -.001 -1.04 .30 
Financial x Age .0003 .35 .72 
Physical x Age .001 .82 .41 
* Includes controls for sex, BMI, triglycerides, smoking status, use of prescription pain medication 
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Table 35: CSS-by-age as predictor of baseline IL-6* 
 
Stress 
 
b
 
t
 
p
Average CSS x Age .001 .32 .75 
Marital x Age -.0004 -.53 .60 
Parental x Age .001 2.32 .02 
Filial x Age .001 1.61 .11 
Occupational x Age .0001 -.14 .89 
Ecological x Age < .0001 -.70 .49 
Financial x Age < .0001 .26 .80 
Physical x Age -.0001 -.69 .49 
* Includes controls for BMI, current rheumatologic condition, smoking status 
5.5 ANCILLARY ANALYSES 
To further clarify the present results, we conducted a set of supplementary analyses.  These 
analyses included examination of (1) baseline IMT as a moderator of the association between 
CSS subscales and (a) inflammatory markers and (b) IMT change; (2) use of antihypertensive or 
lipid-lowering medication as a moderator of the association between CSS subscales and (a) 
inflammatory markers and (b) IMT and plaque change; (3) the utility of a “threshold model” of 
chronic stress15 as a predictor of (a) IMT and plaque change and (b) inflammatory markers; (4) 
inflammatory marker levels as moderators of the association between CSS subscales and IMT 
and plaque change; and (5) interactions between CSS subscales as predictors of (a) IMT and 
                                                 
15 CSS subscales were re-scored such that individuals who scored at or above the sample median on a given subscale 
were assigned a score of “1” on that subscale, whereas persons who scored below the median were assigned a score 
of “0.”  The re-scored total CSS score was computed as the sum of the rescored subscales.  A second set of analyses 
was conducted wherein 95th percentile scores rather than median scores were used to define the threshold. 
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plaque change and (b) inflammatory markers.  As results from most of these analyses did little to 
clarify the present report’s major findings, associated data will not be presented here.  However, 
it should be noted that baseline IMT was a significant moderator of the association between 
physical stress and IMT change (b = .07, t = 2.49, p < .05) such that physical stress predicted 
greater IMT change among persons with higher levels of baseline IMT (b = .02, t = 3.68, p < 
.001) but not among those with lower baseline IMT levels (b = -.0003, t = -.04, p = .97).     
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6.0  DISCUSSION 
The primary aim of the present study was to examine whether (a) self-reported chronic life stress 
predicts 3-year change in carotid artery IMT and plaque, and (b) the association between stress 
and these 2 markers of subclinical CVD is explained by a mediational pathway involving 
elevations in circulating inflammatory markers (IL-6 and CRP).  Specifically, we anticipated that 
more life stress would be associated with (a) greater IMT and plaque progression; and (b) higher 
levels of circulating inflammatory markers.  Furthermore, we expected that the elevated 
inflammatory marker levels associated with high chronic stress would explain, in part, the 
association between stress and the cardiovascular outcome variables.  A secondary aim of the 
present study was to examine whether individual differences in cardiovascular reactivity to 
laboratory challenge (CVR) moderates the association between life stress and progression of 
IMT and plaque.  Our expectation was that the association between stress and progression would 
be stronger among high reactors relative to low reactors.  Results did not provide strong support 
for the above hypotheses.  Furthermore, exploratory analyses by sex and age failed to reveal 
support for the predicted associations among subgroups of the sample population. 
 
6.1 CHRONIC LIFE STRESS AS A PREDICTOR OF IMT AND PLAQUE CHANGE 
In contrast to our expectations, the aggregated CSS score was not associated with 3-year change 
in IMT or plaque.  When individual CSS subscales were examined, physical stress emerged as an 
independent predictor of IMT change, such that higher reports of physical stress were associated 
with a greater increase in IMT during the follow-up.  This finding is difficult to interpret as it is 
uncertain to what extent psychological versus purely physical dimensions of this type of stress 
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are contributing to greater IMT progression.  It is possible that frustration associated with, for 
example, having trouble getting around, could be associated with chronic activation of the HPA 
and SNS which might have implications for early atherogenesis.  Alternatively, the association 
between reports of greater physical stress and greater IMT progression could be due to generally 
less healthy persons showing more early vascular pathology.  In exploratory analyses (not shown 
here), we attempted to isolate the effect of the subjective, or psychological dimension of physical 
stress by examining the single item “Did any physical disabilities place an extra burden on you?”  
Scores on this single item were not significantly associated with IMT change.  This lack of 
statistical association may be due to a true lack of association between the psychological 
dimension of physical stress and IMT change, or it may be due to the fact that we evaluated the 
association using only a single-item measure.   
Interestingly, ancillary analyses revealed that the association between physical stress and 
IMT change was moderated by baseline IMT.  Specifically, physical stress predicted IMT 
change when examined among persons whose baseline IMT values were at least one standard 
deviation above the sample mean but not among those whose IMT values were at least one 
standard deviation below the mean.  Given that physical stress was unrelated to baseline IMT in 
the present sample, these findings suggest that physical stress may be a better predictor of 
advanced lesion progression than of initial lesion development.      
Also notable is a significant inverse univariate correlation between scores on the marital 
stress subscale and IMT change, such that more marital stress was associated with less IMT 
progression.  This association was attenuated, however, when marital stress was examined in a 
model that included covariates for age and sex.  In the present sample, women and younger 
persons reported more marital stress relative to men and older persons.  Women and younger 
persons also showed less progression compared to their male and senior counterparts.  Thus, the 
significant inverse univariate correlation between marital stress and IMT change likely reflected 
the fact that higher marital stress was reported by persons who because of their sex and age, 
showed relatively less progression.  It is important to note that while the inverse association 
between marital stress and IMT progression no longer was statistically significant following 
control for age and sex, a marginal trend remained apparent.  Two of the 3 items that comprise 
the marital stress subscale measure frequency of disagreements between the respondent and his 
or her spouse over (a) monetary spending and (b) balance of give-and-take.  It is possible that 
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individuals who report more frequent disagreements with their spouses over these issues tend to 
be the member of the couple who takes greater responsibility for the financial and physical 
wellbeing of the household and family.  In this way, a higher score on the marital stress subscale 
might be an indirect marker of a generally conscientious personality.  Conscientious persons 
might take better care of their own health, and thus show less IMT progression.    
Neither aggregate CSS scores nor scores on any of the individual subscales predicted 3-
year change in plaque.  Plaque measures are thought to provide a more precise index of true 
atherosclerotic disease relative to IMT which may be influenced by processes unrelated to 
atherogenesis.  Thus, that physical stress failed to predict change in plaque suggests that the 
association between physical stress and IMT may be due to a relation with vascular aging rather 
than atherogenic processes.  It should be kept in mind however, that IMT is scored more 
objectively than plaque.  Furthermore, IMT measurement is associated with a sizable body of 
validation evidence, whereas plaque measurement is not.  It is possible that the association 
between physical stress and plaque change was negatively influenced by the use of a 
comparatively unreliable dependent variable measure.  
The general lack of positive association between chronic stress and the cardiovascular 
outcomes examined in the present study stands in contrast to existing research that has identified 
a link between chronic stress and cardiovascular disease risk.  One explanation for this apparent 
discrepancy is that the majority of research on chronic stress and CVD has focused on clinical 
disease outcomes.  It is possible that chronic stress is a more reliable predictor of clinical events 
than of changes in vascular morphology that may be indicative of earlier, subclinical disease 
progression.  Clinically manifest CVD (i.e., myocardial ischemia, infarction, or sudden cardiac 
death) is triggered by transient pathologic alterations in cardiovascular physiology such as 
increased cardiac demand, increased hemoconcentration, coronary constriction, arrhythmia, and 
plaque rupture.  It is possible that the condition of being chronically stressed is associated with 
exposure to phenomena that elevate the probability of experiencing such pathologic changes.  
For example, experiences of chronic difficulty have been found to give rise to severe acute life 
stressors (Brown & Harris, 1989).  Research has shown that acute mental stress may act as a 
trigger for transient ischemic episodes (Gullette et al., 1997), lower the threshold for malignant 
tachycardia (Verrier & Lown, 1984), and influence plasma volume and density (Patterson, 
Krantz, & Jochum, 1995).  Thus, the association between chronic stress and clinical CVD risk 
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that has been reported in previous research might be contingent upon the experience of frequent 
acute stressors.  In other words, the condition of chronic stress may elevate the likelihood of 
experiencing an acute stressor, which then could act as a trigger for an acute coronary event.  
Future research might investigate the role of acute stressors in the association between chronic 
stress exposure and CVD risk. 
To propose that chronic psychosocial stress may be a better predictor of clinical events 
than of early, subclinical disease progression is not to suggest that psychosocial factors are 
unrelated to early cardiovascular pathogenesis.  The present study, however, may not have had 
sufficient power to detect such an association.  Six known prospective studies have examined 
associations between psychosocial factors and IMT and/or plaque progression (Everson, Kaplan 
et al., 1997; Gallo et al., 2003; Julkunen et al., 1994; J. Lynch, Kaplan et al., 1997; J. Lynch, 
Krause et al., 1997; Paterniti et al., 2001).  The average length of follow-up among these studies 
was 3.6 years (range 2.0 to 5.2 years), which is comparable to the follow-up time employed by 
the present study.  The average sample size, by comparison, was n = 657, with four studies 
employing sample sizes in excess of n = 700.  Although five of these six studies reported 
significant associations between psychosocial factors and selected outcomes, corresponding 
effect sizes were very small.  As reported in an earlier section (see Methods, Table 1), the 
aggregate effect size calculated across these studies for the association between psychological 
factors and IMT change was r = .11 and between psychological factors and plaque change was r 
= .15.  Thus, the corresponding power of the present study to detect these effects was .47 and .71, 
respectively.  It is possible that the present data might have supported the study hypotheses had 
our sample size been larger.   
It should be noted that three of the five studies that reported significant associations 
between psychosocial factors and IMT and plaque progression were derived from the KIHD 
study, which recruited participants from a region of Finland that is characterized by residents 
with high CVD risk factor profiles (Julkunen et al., 1994; J. Lynch, Kaplan et al., 1997; J. Lynch, 
Krause et al., 1997).  It is possible that the effects of psychological factors, such as chronic 
stress, on subclinical disease progression are more influential among persons who are at high 
biological or behavioral risk for CVD.  In exploratory analyses (data not shown) we examined 
whether baseline risk factors moderated the association between chronic stress and IMT and 
plaque progression.  For example, we explored whether smokers and persons with higher 
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baseline cholesterol levels were more likely to show an association between chronic stress and 
IMT and plaque progression relative to non-smokers and persons with low baseline cholesterol.  
The results of these analyses provided no significant findings, which largely may have been due 
to the fact that few participants in the present sample showed an especially high risk factor 
profile.  Nevertheless, our finding that physical stress appeared to influence IMT progression 
only among persons with higher baseline IMT scores is consistent with the possibility that 
psychosocial stress may have an exacerbating effect on early CVD progression among persons 
already at risk.     
Another explanation for the discrepancy between the present findings and those reported 
by previous research involves the employed measure of chronic stress.  Preliminary analyses 
indicated that scores on the CSS correlate in expected directions with scores on established 
measures of stress and personality.  However, the CSS may lack construct validity with regard to 
CVD risk.  In other words, the CSS may not measure the “toxic” features of chronic stress that 
are relevant to physiologic processes that contribute to IMT and plaque progression.  For 
example, the CSS occupational stress subscale correlated with the demand and workplace social 
support dimensions of the Karasek Job Content Questionnaire (R.A. Karasek, 1985) but not with 
the decisional control dimension.  Both low job control (Bosma et al., 1997) and high 
demand/control imbalance (R.A.  Karasek et al., 1988) have been associated with elevated CVD 
risk.  Perhaps additional information on participants’ perceived level of workplace control would 
have provided a measure of occupational stress that is more closely associated with subclinical 
disease progression.   
A second issue pertaining to the CSS that may explain the lack of significant findings 
concerns the reliability of the CSS as a measure of chronic stress.  By design, the CSS is a 
retrospective measure in that it asks respondents to reflect on their experience of stress during the 
6-month reporting period.  Retrospective reports often are biased by conditions at the time of 
reporting (A. A. Stone et al., 2000).  Said differently, participants’ interpretations of CSS items, 
when encountered on 2 or more occasions, might differ depending on factors present at the time 
of CSS administration.  It also is possible, however, that the phenomena being assessed by the 
CSS are not stable over the course of a 6-month reporting period.  In this way, participants’ 
reports of stress during the preceding 6 months might have been unduly influenced by current 
stress levels, which may or may not reflect stress experienced during the previous 6 months.  
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Insofar as current stress is atypical, CSS scores might represent a high or low stress “episode” 
rather than a chronic stress condition.  It has been suggested that episodic stressors might more 
likely be associated with the transition from subclinical to clinical CVD rather than long term 
progression of early subclinical disease as might be represented by change in IMT and plaque 
(Kop, 1997).  Thus, if CSS scores reflect episodic rather than chronic stress, it is unlikely that 
they would correlate with changes in the 2 cardiovascular outcome measures examined in the 
present study.  A replication of the present study might include multiple administrations of the 
CSS to gain a more reliable measure of participants’ experiences of chronic life stress. 
In sum, with the exception of the physical stress finding, the present data do not support 
an association between chronic stress and IMT and plaque progression.  This lack of association 
contrasts with findings of previous research which suggest a link between psychosocial factors 
and these two markers of early cardiovascular pathogenesis.  Two features of the present study 
likely compromised the ability to detect significant associations:  (1) the relative good health of 
the employed sample; and (2) the limited power of the present study to detect small effect sizes 
of the kind reported in the extant literature (see Table 1).   The small sizes of the effects reported 
by previous research, in combination with the general lack of effect reported here, suggest that 
IMT and plaque change may be relatively insensitive indices of the influence of psychosocial 
factors on cardiovascular health.  Given that the average follow-up time employed by existing 
studies of psychosocial factors and early CVD progression (including the present study) was 3-4 
years, it is possible that the apparent insensitivity of IMT and plaque measures to psychosocial 
influences is due to an insufficient amount of time being allowed to detect a sizable effect.  The 
effects of chronic psychosocial stress, for example, may not be apparent until reaching a certain 
“temporal threshold.”  Future research might examine the association between chronic stress and 
early CVD progression during a longer period of follow-up, and with multiple measures of 
chronic stress during that time.  Future studies also might investigate whether psychosocial stress 
plays a more influential role in the progression of early cardiovascular pathogenesis among 
vulnerable or at-risk populations.  Potential risk categories might include poor health behaviors, 
family history of CVD, diabetes, or rheumatic disease, low socioeconomic status, and unhealthy 
childhood environment.  
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6.2 INFLAMMATORY MARKERS AS PREDICTORS OF IMT AND PLAQUE 
CHANGE 
CRP was unrelated to 3-year change in either IMT or plaque.  IL-6 was unrelated to IMT change.  
Unexpectedly, higher levels of IL-6 were associated with a reduced probability of showing an 
increase in plaque lesion number during the follow-up.  As already discussed, suggestive 
evidence from a large and growing literature supports a prospective association between CRP 
(and to a lesser extent, IL-6) and future CVD risk among initially healthy persons (J. Danesh et 
al., 2004).  A considerably smaller body of research has explored whether inflammatory markers 
are associated with intima-media thickening or the appearance of eccentric plaque (Cao et al., 
2003; Chapman, Beilby, McQuillan, Thompson, & Hung, 2004; Folsom, Aleksic, Catellier, 
Juneja, & Wu, 2002; Folsom et al., 2001; Hak et al., 1999; Hulthe, Wikstrand, & Fagerberg, 
2001; Sitzer et al., 2002; Tracy et al., 1997; van der Meer et al., 2002; T. J. Wang et al., 2002; 
Willeit et al., 2000).  In general, findings from this latter group of studies have been mixed.  For 
example, Tracy and colleagues detected no association between CRP and IMT when examined 
cross-sectionally among participants in the Cardiovascular Health Study (CHS) (Tracy et al., 
1997).  By comparison, van der Meer and colleagues found CRP, but not IL-6, to be associated 
cross-sectionally with IMT among participants in the Rotterdam Study (van der Meer et al., 
2002).  Higher CRP levels also were associated with a higher plaque score among these 
individuals (van der Meer et al., 2002).  The single prospective study reported a positive 
univariate association between baseline CRP and appearance of new atherosclerotic lesions 5 
years later (Willeit et al., 2000).  CRP was unrelated, however, to progression of existing lesions 
during the 5-year follow-up.  Furthermore, when analyses included covariate terms for traditional 
risk factors, the effect of CRP on new lesion development no longer was significant (Willeit et 
al., 2000).   
One explanation for the inconsistency of this literature concerns the multiple operational 
definitions of plaque and IMT that have been employed across studies.  Plaque, for example, has 
been defined in terms of protrusion into lumen and wall texture (Willeit et al., 2000), the 
proportion of sites with detectable plaque (van der Meer et al., 2002), focal thickening of > 1 mm 
(Chapman et al., 2004), and a distinct area > 50% thicker than surrounding regions (Hulthe et al., 
2001).  Recall that the present study operationalized plaque change as a binary variable that 
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indicated whether the number of visually apparent plaque lesions increased during the 3-year 
follow-up period.  By comparison, carotid IMT scores have been derived by averaging near and 
far wall measurements (Cao et al., 2003; Hak et al., 1999; Tracy et al., 1997; van der Meer et al., 
2002; T. J. Wang et al., 2002), or like the present study, by examining the far wall only 
(Chapman et al., 2004; Hulthe et al., 2001; Sitzer et al., 2002).  Moreover, carotid IMT measures 
have been computed as the average of common, internal, and bulb regions (Folsom et al., 2002; 
Folsom et al., 2001; Sitzer et al., 2002; T. J. Wang et al., 2002), common and internal regions 
(Cao et al., 2003; Tracy et al., 1997), common and bulb regions (Hulthe et al., 2001), and the 
common region alone (Hak et al., 1999; van der Meer et al., 2002).  One recent study found that 
traditional cardiovascular risk factors may differentially influence IMT in the common, internal, 
and bulb segments of the carotid artery (Schott et al., 2004).  It is possible that CRP and IL-6 
also may have differential effects on the various segments of the carotid artery.  Given the 
heterogeneity in outcome measures, the extant literature on inflammatory markers and 
subclinical CVD is difficult to interpret.  Accordingly, it is difficult to assess how well the 
present findings fit with that research.  Future work might focus on the standardization of IMT 
and plaque measures.    
Another explanation for the lack of a consistent association between inflammatory 
markers and surrogate CVD endpoints concerns the extent to which IMT and plaque measures 
reflect disease processes in which inflammation is thought to play a role, namely, atherogenesis 
and thrombosis.  A criticism of IMT as an index of subclinical CVD is that the measure reflects 
properties of the vasculature other than atherosclerosis.  Specifically, it has been proposed that 
non-atherosclerotic thickening of the intima and media may occur as an adaptive response to 
mechanical stress or aging (Glagov, Zarins, Giddens, & Ku, 1988).  Thus, insofar as adaptive 
processes contribute substantially to 3-year IMT change in the present sample, it is not 
unreasonable that CRP and IL-6 should fail to predict that change.   
By comparison, plaque measures are thought to provide a fairly specific index of 
atherosclerosis.  The present study failed to detect an association between CRP and the 
likelihood of change in plaque lesion number during the 3-year follow-up period.  A lack of 
independent association between CRP and plaque has been reported in 4 of 5 previous cross-
sectional studies as well (Chapman et al., 2004; Folsom et al., 2001; Hulthe et al., 2001; Willeit 
et al., 2000).  Unexpectedly, the present study found IL-6 to be inversely associated with plaque 
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change, such that higher levels of IL-6 predicted a decreased likelihood of change in lesion 
number.  As there is no reason to expect that higher IL-6 levels would have a protective effect on 
plaque progression, this association likely reflects a chance occurrence.  To date, only 2 other 
known studies have examined the association between IL-6 and carotid plaque (Chapman et al., 
2004; van der Meer et al., 2002).  In neither study was IL-6 an independent predictor of prevalent 
plaque measures.  Taken together, the findings of the present study, in combination with those 
from previous research suggest that inflammation is an unlikely correlate of early, subclinical 
atherosclerosis.  However, it is possible that the relation between inflammation and 
atherosclerosis is not one that can be estimated by examining quantitative plaque measures as 
outcomes.  It has been suggested that the association between inflammation and risk for clinical 
cardiovascular events may be due, in part, to the contribution of inflammation toward 
development of unstable plaques (Willerson & Ridker, 2001).  Risk of plaque rupture has been 
found to correlate poorly with degree of stenosis (Fuster & Lewis, 1994).  Thus, it is possible 
that inflammatory processes may influence the structural integrity of early atherosclerotic lesions 
without affecting to the quantity of lesion produced.   
Another factor that might have influenced the ability of the present study to detect a 
significant association between inflammatory markers and IMT and plaque change in the present 
sample involves the relative distributions of the predictor and outcome variables among men and 
women.  CRP levels tend to be higher in women relative to men (McConnell et al., 2002).  By 
comparison, IMT and plaque change tend to be greater in men relative to women (Chambless et 
al., 2002).  Inspection of Figures 6, 7, 9, and 10 (inflammatory markers) and Figures 15 and 16 
(IMT) demonstrate that these sex differences are apparent in the present sample.  Thus, it is 
unsurprising that analyses among the entire sample should result in null findings.  Analyses 
stratified by sex (see Appendix E, Tables E-7 and E-8), however, similarly resulted in a lack of 
correlation between inflammatory markers and IMT and plaque change.  Given the reduction in 
sample size associated with sex-specific analyses, it is possible that we simple did not have 
sufficient power to detect significant correlations.  Additionally, among the women in our 
sample, age was negatively rather than positively associated with CRP concentrations.  As IMT 
increases with age, the respective influences of CRP and age on IMT progression were counter to 
one another, and thus likely contributed to the lack of effect for CRP.   
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In sum, the data presented here fail to support an association between circulating 
inflammatory marker levels and 3-year progression of IMT and plaque.  This failure of the 
present study to detect a significant association is not inconsistent with the existing research in 
this area, which is comprised largely of mixed outcomes.  The cloudiness of the research on 
inflammation and IMT and plaque contrasts remarkably with the literature supporting a 
prospective association between CRP and incidence of clinical CVD events (Danesh et al., 
2004).  One might infer from the difference in consistency between these two literatures that 
inflammation plays a larger role in later rather than earlier stages of cardiovascular pathogenesis. 
Findings from experimental animal research, however, suggest a potential causal role of IL-6 and 
CRP in early atherogenesis (Rus et al., 1996; Torzewski et al., 2000).  Thus, investigation of 
these two inflammatory markers as predictors of IMT and plaque progression in humans is not 
unreasonable.  Given the biologic plausibility of inflammatory factors playing a causal role in 
atherosclerosis progression, one direction that future research might take is to examine the 
prospective association of inflammation with markers of early cardiovascular pathogenesis (e.g., 
IMT, plaque, endothelial function) among children over the course of several years.  As children 
likely would show negligible vascular pathology, researchers might more easily be able to 
identify early associations between inflammation and CVD.  Additionally, future research might 
investigate the interplay of inflammation and subclinical disease markers in the prediction of 
future clinical events.  No known published prospective studies of CRP and clinical CVD have 
examined baseline levels of atherosclerosis.  It is possible that inflammatory activity influences 
the integrity of pre-existing plaques such that they are more prone to rupture, and thus initiating 
acute events.      
6.3 CSS AS PREDICTOR OF BASELINE INFLAMMATORY MARKER LEVELS 
The present study failed to detect a significant independent association between CSS scores and 
baseline inflammatory marker levels.  It should be noted that the physical stress subscale of the 
CSS did show a positive univariate correlation with CRP.  However, this association lost 
significance when examined in a model that included adjustment for relevant covariates. 
Specifically, BMI and use of prescription pain medications each accounted for a substantial 
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proportion of the variance in CRP associated with physical stress.  Both the physical stress 
subscale of the CSS and prescription pain medication use may be indirect markers of biological 
aging.  Biological age is a construct that is used to describe an individual’s functional status 
relative to his or her chronological peers (Borkan & Norris, 1980).  Findings from human and 
comparative research have shown that biological age does not always parallel chronological age 
(Anstey, Lord, & Smith, 1996; Collier & Coleman, 1991).  Chronological aging is known to be 
associated with chronic, low-grade inflammatory activity (Krabbe, Pedersen, & Bruunsgaard, 
2004).  However, it is unknown whether age-related alterations in inflammation arise as a 
function of an internal “clock” mechanism or whether age-related low grade inflammatory 
activity simply reflects the sum total of age-related physical burden.  It is possible that among the 
present sample, high scores on the CSS physical stress subscale, as well as positive endorsement 
of pain medication use may be identifying individuals who are undergoing more rapid biological 
aging.  Insofar as increased IMT may be a structural marker of vascular aging, the observed 
association between physical stress and IMT in the present sample lends further support to this 
interpretation.  Future research might investigate whether associations between stress and 
physical health outcomes is moderated by individual differences in rates of biological aging. 
The present null findings for CRP are consistent with those reported by a previous study 
that found no significant association between scores on a multidimensional “perceived adversity” 
scale and levels of circulating CRP (Steptoe & Marmot, 2003).  The present results contrast, 
however, with findings from the only other known study to examine whether self-reported 
chronic stress in multiple life domains predicts inflammatory marker levels.  Hapuarachchi and 
colleagues examined associations between scores on several unidimensional stress instruments 
and levels of CRP.  The authors found that CRP correlated positively with measures of 
occupational strain, perceived stress, and psychological stress (General Health Questionnaire, 
GHQ-12), and inversely with measures of job satisfaction and social support (Hapuarachchi, 
Chalmers, Winefield, & Blake-Mortimer, 2003).  It should be noted, however that the average 
age of the sample employed by Hapuarachchi and colleagues was 46 years.  It is possible that 
any effects of stress on CRP levels are more pronounced among younger relative to older 
persons.   
To date, no known studies have examined the association between multidimensional 
chronic life stress and circulating IL-6 levels.  Two studies, however, have examined IL-6 levels 
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among persons who were acting as the primary caregiver for a relative with dementia (Kiecolt-
Glaser et al., 2003; Lutgendorf et al., 1999).  In the earlier study, IL-6 levels were found to be 
higher among older female caregivers relative to (a) older women who were undergoing the 
stress of moving to a new residence; (b) older women who were neither caregivers nor movers; 
and (c) younger women who were neither caregivers nor movers (Lutgendorf et al., 1999).  In 
the more recent study, male and female caregivers showed a larger age-related increase in IL-6 
over 6 years of follow-up relative to men and women without caregiving responsibilities 
(Kiecolt-Glaser et al., 2003).  Thus, it appears that the present IL-6 findings conflict with those 
reported by previous research.  As suggested for the association between chronic stress and the 
present measures of IMT and plaque, it is possible that the CSS does not measure those features 
of chronic stress that are most likely to influence IL-6 levels.  Findings from the 2 studies 
described above suggest that the burden of caregiving might be one type of stress that is 
associated with the activation of physiologic processes that regulate the level of IL-6 in 
circulation.  Given the unpredictable behavior of persons with dementia, informal caregivers of 
dementia patients might spend their days in a constant state of “watchful waiting” that may be 
accompanied by chronic physiologic arousal.  Furthermore, insofar as a caregiver lives with the 
care recipient, there may be limited opportunity to recover from daily psychological stress and 
associated physiologic perturbations.       
Caregiver burden was not explicitly addressed by the CSS.  It is interesting to note, 
however, that the present study detected a significant positive association between filial stress 
and CRP among older participants.  It is possible that older participants might have been 
reflecting on caregiving experiences when responding to items included in the filial stress 
subscale (cf. Appendix A).  By comparison, and contrary to what might be expected, filial stress 
was associated with lower CRP levels among younger participants.  One explanation for this 
counterintuitive finding is that generally more healthy persons (with lower CRP levels) are more 
likely to attend to their families of origin, and thus report higher levels of familial stress.  Similar 
unexpected associations were observed between (a) occupational stress and CRP among all 
younger participants; and (b) parental stress and IL-6 among younger men.  Specifically, among 
younger participants, more occupational stress was associated with lower levels of CRP.  Among 
younger men, more parental stress was associated with lower IL-6.  It is possible that less healthy 
persons (with higher levels of CRP) select themselves out of high-stress jobs, and thus report less 
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occupational stress relative to their healthier counterparts.  A similar explanation might be 
offered for the association between parental stress and IL-6:  less healthy men (with higher levels 
of IL-6) might be less likely to involve themselves in their children’s affairs, and thus report 
relatively lower levels of parental stress.  Alternatively, assuming that parental stress is an 
indirect marker of parental involvement, it may be that being an active parent has a protective 
effect on IL-6 levels among the men in the present sample.  That the above counterintuitive 
findings were observed only among younger participants might be explained by differential 
stress reporting with age.  Findings from previous population research have shown that reports of 
stress tend to decrease with increasing age (Cohen & Williamson, 1988).  Thus, it is possible that 
a generally lower level of stress reporting among older participants may have reduced the 
likelihood of detecting significant associations.   
The lack of a consistent association between chronic stress and circulating inflammatory 
markers does not necessarily indicate that stress is not a correlate of inflammation.  Multiple 
factors contribute to circulating inflammatory marker levels such as age, sex, stage in the 
menstrual cycle, infectious disease status, previous exposure to pathogens, and genetics.  It is 
possible that effects of stress on circulating inflammatory marker levels exist in the present 
sample, but are small.  It is the challenge of future research to determine whether the proportion 
of variance in inflammatory marker levels that may be accounted for by psychological factors 
has significant implications for health.  Alternatively, the effects of stress on inflammation may 
depend on individuals’ status on other factors associated with inflammatory processes.  For 
example, one study found that persons who scored high on a measure of vital exhaustion showed 
higher levels of IL-6 relative to persons who scored low on the measure, especially among 
persons who were seropositive to multiple infectious agents (van der Ven et al., 2003).  Another 
study found that vital exhaustion was associated with elevated levels of CRP only among persons 
who were carriers of the A allele of the TNF-alpha -308 G/A polymorphism (Jeanmonod, von 
Kanel, Maly, & Fischer, 2004).  Taken together, the findings from these 2 studies suggest that 
vital exhaustion may further influence inflammatory marker levels that already are elevated due 
to other factors.  Insofar as these findings for vital exhaustion might be extended to other 
psychosocial factors, such as chronic life stress, it may be important for future studies to consider 
the role of moderating influences when examining an association between stress and 
inflammation.   
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A few procedural issues also might have reduced the ability of the present study to detect 
a significant association between chronic stress and inflammation.  First of all, participants with 
current infectious diseases were not excluded from the blood draw for CRP and IL-6.  Inclusion 
of participants with concurrent infectious or inflammatory conditions potentially could have 
masked the effects of stress on inflammatory markers.  However, use of CRP standard cut points 
should have reduced the prevalence of such individuals in the present sample.  Another factor 
that might have influenced the ability of the present study to detect an association between 
chronic stress and inflammation concerns the timing of the administration of the CSS relative to 
the blood draw for inflammatory markers.  Baseline blood draws were taken during the initial 
medical screening, whereas the CSS was administered, on average, 5.1 months later (range = 2.5 
to 14.0 months).  Although the average lag between inflammatory marker and stress 
measurements fell within the reporting period of the CSS (i.e., past 6 months), approximately 
17% (n = 48) of the participants were administered the CSS more than 6 months after the blood 
draw.  Insofar as CSS scores may have been biased toward more recent stress experiences, it is 
possible that the true association between inflammatory marker levels and concurrent stress 
might have been minimized. 
In sum, the findings of the present study do little to clarify the small and largely 
inconclusive existing literature on chronic psychosocial stress and circulating markers of 
inflammation.  A fundamental challenge to this area of study is the fact that inflammatory 
markers simultaneously index the influence of chronic and acute factors.  For this reason, studies 
that measure inflammatory markers as outcomes must employ careful controls at multiple levels.  
Ideally, participants would be free of acute or chronic infectious or inflammatory disease, have 
suffered no recent physical injuries, be taking no medications with anti-inflammatory effects, be 
roughly the same age, and, among women, be at approximately the same phase of the menstrual 
cycle.  Given the obvious difficulty in obtaining such an ideal sample, it is no surprise that 
relatively few human studies of chronic stress and inflammation have been conducted.  
Interestingly, there are no known published studies to date that have investigated the association 
between chronic stress and circulating inflammatory markers among laboratory animals.  A 
number of studies have investigated the influence of chronic or repeated stress on the ability of 
stimulated cells to produce inflammatory cytokines in vitro (Avitsur, Kavelaars, Heijnen, & 
Sheridan, 2005; Bartolomucci, Sacerdote, Panerai, Peterzani, Palanza, & Parmigiani, 2003). 
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Whether increased production of inflammatory cytokines (or decreased production of cytokines 
with anti-inflammatory effects) by stimulated cells can lead ultimately to chronic elevations in 
circulating levels of these markers is unknown, and ought to be a focus of future research.  
Perhaps now is the time to take advantage of the control permitted in the conduct of infrahuman 
animal research to examine the effects of chronic stress on circulating inflammatory markers.  
Experimental animal studies would allow researchers to assess the effects of standardized 
chronic stressors on inflammatory outcomes.  Further, transgenic animals that are bred to 
develop chronic inflammatory conditions (e.g., rheumatoid arthritis) can be exposed to varying 
levels of chronic stress to determine whether stressor exposure has an exacerbating effect among 
vulnerable individuals.  Knowledge gained from such research would provide researchers with a 
better foundation on which to base human studies.       
6.4 CVR AS A MODERATOR OF THE ASSOCIATION BETWEEN CHRONIC 
STRESS AND IMT AND PLAQUE CHANGE 
A secondary aim of the present study was to examine whether trait CVR moderates the 
association between chronic stress and IMT and plaque change.  As the main effect of stress on 
the cardiovascular outcome variables was not significant, we modified our original hypothesis 
that stress would be a stronger predictor of IMT and plaque change among high relative to low 
reactors.  Rather, we examined the possibility that a significant main effect might emerge when 
assessed among persons who showed high levels of reactivity but not among those who showed 
low reactivity.  We detected only one significant CVR-by-chronic stress interaction:  diastolic 
reactivity moderated the association between filial stress and IMT change.  Analysis of simple 
effects revealed a cross-over interaction such that more filial stress was associated with less IMT 
change when examined among high reactors and with greater IMT change when examined 
among low reactors.  Neither association, however, achieved statistical significance (p’s > .10).  
Given the number of CVR-by-chronic stress analyses that were conducted, this single significant 
interaction and associated counter-intuitive effects likely were a consequence of chance. 
Interactive effects of psychosocial factors and CVR on IMT and plaque progression have 
been described in 2 reports from the Kuopio Ischemic Heart Disease Study (KIHD) (Everson et 
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al., 1997; J. W. Lynch, Everson, Kaplan, Salonen, & Salonen, 1998).  The first report examined 
CVR as a moderator of the association between workplace demands and atherosclerosis 
progression (Everson et al., 1997), whereas the second examined the interactive effects of CVR 
and SES (i.e., income and education) on progression of atherosclerosis (J. W. Lynch et al., 
1998).  Everson and colleagues reported significant workplace demand-by-CVR interaction 
effects both for a model that included change in mean IMT as well as for a model that examined 
change in plaque height.  This finding stands in contrast to the results of the present study, which 
showed no moderating effect of CVR on the association between the occupational stress subscale 
of the CSS and IMT and plaque progression.  By comparison, Lynch and colleagues reported 
only marginal effects for the (a) income-by-CVR interaction, and (b) education-by-CVR 
interaction on progression of mean IMT (p’s < .10), and no significant interaction effects when 
plaque height was examined as the outcome (J. W. Lynch et al., 1998).  In combination, these 2 
reports from the KIHD study suggest that the moderating effect of CVR on the association 
between chronic stress and IMT and plaque progression, although apparent, may be small.  It is 
possible that the present study lacked sufficient power to detect a small-size moderating effect on 
a non-significant main effect association.  As indicated by the power analyses presented in the 
Methods, the power of the present study to detect a significant moderating effect of CVR on the 
association of psychosocial factors with IMT and plaque change was .17 and .10, respectively.  
This explanation may be especially relevant to the present study’s failure to find a significant 
moderating effect of CVR on the association between occupational stress and IMT and plaque 
progression, as only a subgroup of the present sample were employed at the time the CSS was 
administered (n = 161).  
6.5 ADDITIONAL LIMITATIONS OF THE PRESENT STUDY 
Beyond those already discussed, a few additional limitations of the present study need be 
addressed.  First of all, the present sample was composed of healthy, older adults with no 
evidence of pre-existing CVD at baseline.  As CVD of any type is not uncommon among persons 
in the recruited age range, it is possible that the older adults who comprised the present sample 
represent a comparatively protected group, and therefore may be less likely to demonstrate 
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robust evidence of our predicted associations.  Another limitation of the present study is that 
participants received only one baseline blood draw for inflammatory markers.  Previous research 
has reported fairly large intra-individual variation in serum CRP (Ledue & Rifai, 2003).  Thus, it 
has been recommended that the mean of 2 independent CRP measurements, separated by at least 
2 weeks, should be used to establish risk of future clinical CVD events (Pearson et al., 2003).  
That our single measurement may not have provided an accurate assessment of true baseline 
inflammatory marker levels could have weakened both the association between (a) stress and 
inflammation and (b) inflammation and IMT and plaque progression.  A third disadvantage 
associated with the present study is that IMT and plaque were assessed on only 2 occasions.  It is 
possible that IMT progression, for example, does not follow a linear trajectory.  A non-linear 
IMT progression trajectory may have implications for the questions posed by the present report, 
as the association between (a) chronic stress and/or inflammatory markers and (b) IMT change 
may depend on the point in the trajectory of progression at which baseline is assessed.  Extension 
of data collection to a third time-point would permit investigation of non-linear IMT growth 
trajectories, and thus provide and opportunity for these issues to be addressed.  An additional 
IMT data-point also would increase the reliability of an observed linear trajectory.  Another 
limitation of the present sample that was alluded to above concerns the modest sample size.  This 
limitation was especially apparent when examining the predictions we made regarding the 
moderating effects of sex on the association between CSS subscales and IMT and plaque change.  
For example, contrary to expectations occupational stress was not a better predictor of IMT 
change among men relative to women.  Given that only 161 (89 men; 72 women) of the 276 
participants in the present study were employed at the time of enrollment, the power to detect a 
significant occupational stress-by-sex interaction was somewhat compromised.  It is possible that 
the predicted effects might have been detected among a larger population.  Finally, it should be 
reiterated that both atherogenic and vascular remodeling processes contribute to IMT, thus 
calling into question whether change in IMT is an accurate measure of true atherosclerotic 
progression.  In this way, had we detected a significant association between CSS scores and IMT 
progression, it would have been unclear as to which aspect of disease progression chronic stress 
was influencing.  
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6.6 CONCLUSIONS AND FUTURE DIRECTIONS 
Results from the present study did not show strong support for the proposed model that links 
chronic stress with IMT and plaque progression via a mediational pathway involving elevations 
in circulating inflammatory markers.  One interpretation of the lack of significant findings is that 
the proposed model does not accurately describe the true association between chronic stress, 
inflammation, and progression of carotid artery IMT and plaque.  Said plainly, inflammation 
may not be a physiologic mechanism by which chronic stress influences CVD risk.  An 
alternative interpretation is that the expected associations do exist, but were not detected by the 
present methods.  For example, it is possible that the employed measure of chronic stress did not 
capture specific features of psychosocial stress that are relevant to health outcomes, such as 
alterations in circulating inflammatory markers or progression of markers of subclinical CVD.  
Future work might explore whether various dimensions of stress, for example, elements of low 
control or interpersonal tension, relate differentially to health outcomes.  It also is possible that 
continuous exposure to a single chronic stressor, as suggested by high scores on CSS subscales, 
is not as relevant to health outcomes as is serial exposure to multiple acute or episodic stressors.  
There is evidence to suggest that continuous exposure to a homotypic stressor may result in 
habituation of the norepinephrine response to that stressor (Terrazzino, Perego, & De Simoni, 
1995).  Insofar as SNS activation is fundamental to the production of stress-related physical 
pathology, habituation of sympathetic response to a chronic psychosocial stressor could have 
implications for the proposed association between chronic stress and CVD.  Future studies might 
seek to examine whether sustained chronic stress from a single source or serial exposures to 
multiple acute or episodic stressors show differential associations with health outcomes.   
Alternatively, assessment of stress alone may be insufficient to detect an effect on health 
outcomes.  Individuals’ appraisal of a stressor also may dictate whether that stressor is 
physiologically toxic (Lazarus & Folkman, 1984).  For example, one recent study found that the 
severity of medical students’ appraisals of one or more of 5 experienced stressful events (e.g., 
death of family member; financial problems) was inversely associated with reports of perceived 
health and health behaviors (Hojat, Gonnella, Erdmann, & Vogel, 2003).  Trait factors, such as 
personality, also might influence whether the experience of a given stressor is associated with 
pathophysiologic sequelae.  Hostility, for example, has been found to moderate the extent of 
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CVR during an anagram task with harassment such that high hostile persons showed more 
reactivity than low hostile persons (Suarez & Williams, 1989).  The moderating role of 
individual differences in personality and coping was suggested by the nonhuman primate 
research conducted by Kaplan and colleagues (J. R. Kaplan et al., 1982).  Results indicated that 
stress-associated atherosclerosis progression was especially marked in dominant males.  Thus, it 
may be of interest to future studies to examine appraisal, coping, and personality in addition to 
chronic stress to determine whether these factors moderate the association between stress and 
disease.   
It is possible that the present study did not employ appropriate methods for assessing the 
association between circulating inflammatory markers and early cardiovascular pathology.  The 
histological composition of atherosclerotic lesions changes as CVD progresses from the initial 
subclinical stages to manifest clinical pathology (Stary et al., 1995).  Moreover, lesion types 
differ in terms of the timing of earliest onset.  Initial lesions, for example, that are characterized 
by isolated macrophages and foam cells, can appear as early as the first decade of life.  By 
comparison, complicated lesions that are characterized by lipid involvement, fibrosis, and 
calcification tend to appear only during the fourth decade of life or later (Stary et al., 1995).  It is 
likely that inflammatory factors have differential effects on lesion progression at earlier and later 
stages of CVD pathogenesis.  Results from one recent comparative study suggest that 
inflammatory activities, such as the recruitment of white blood cells by endothelial adhesion 
molecules, might be more important during the initiation phase of lesion development than 
during later growth phases (Lessner, Prado, Waller, & Galis, 2002).  Insofar as inflammation 
might be a mediating mechanism that links chronic stress and CVD, it might be beneficial for 
future studies to explore the associations examined here across the lifespan, thus permitting the 
examination of the proposed effects at various stages of disease development. 
The importance of considering the role of maturational stages and processes was 
underscored by our findings for the physical stress subscale of the CSS.  As discussed above, it is 
possible that the physical stress subscale is an indirect marker of biological aging.  Just as stress 
might have differing effects on atherosclerosis development at various stages of disease 
development, so too might physiologic correlates of stress differ as a function of biological 
aging.  The influence of biological aging on inflammatory response to stress was suggested by 
the findings of a recent study that compared changes in CRP levels following acute laboratory 
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stress among persons with (a) rheumatoid arthritis, and (b) osteoarthritis (Veldhuijzen van 
Zanten, Ring, Carroll, & Kitas, 2005).  Following completion of mental arithmetic with 
harassment while tilted to a 64-degree head-up-tilt, rheumatoid arthritis patients showed a greater 
pre- to post-task increase in serum CRP relative to osteoarthritis patients (Veldhuijzen van 
Zanten et al., 2005).  Autoimmune diseases, such as rheumatoid arthritis are associated with 
accelerated “immunosenescence” (Brod, 2000).  In other words, younger persons with 
autoimmune conditions display an immunologic profile similar to what is typical of 
comparatively healthy older persons.  Thus, it might be said that the immune systems of the 
rheumatoid arthritis patients included in the Veldhuijzen van Zanten et al. study had undergone 
more advanced biological aging relative to the osteoarthritis patients.  Accordingly, group 
differences in CRP response to stressor exposure might have been accounted for by differences 
in biological aging.   
In addition to potentially acting as a moderator of the physiologic response to stress, 
accelerated biological aging might be a mechanism by which stress influences disease risk.  One 
recent study found that healthy women’s reports of perceived stress were associated with 
markers of cellular aging, such as reduced telomere length, lower telomerase activity, and higher 
oxidative stress (Epel et al., 2004).  As tissues from different organ systems age at different rates, 
the identification of a single marker of biological aging is unlikely.  A more feasible direction for 
future research might be to identify reliable markers of biological aging for individual organ 
systems.  Research of this nature currently is being conducted (Warner, 2004).  Relevant system-
specific markers of aging then could be incorporated into studies of stress and disease, and 
examined as mediators or moderators of the stress disease association.    
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APPENDIX A 
Table 36: CSS subscale items 
 
Subscale/Items 
Marital stress 
- Did your spouse expect more from you than he or she was willing to give back? 
- Did your spouse spend money in ways you thought unwise? 
- Did problems experienced by your spouse place an extra burden on you? 
Parental stress 
- Did you wonder if your children were trying hard enough to prepare for the life ahead of them? 
- Did you have to give attention to your children failing to get along with others? 
- Did your children seem to ignore your guidance and advice? 
- Did problems experienced by your children place an extra burden on you? 
Filial stress 
- Was one of your parents or some other older relative complaining or critical of you? 
- Did you feel responsible for the care and well-being of a parent or any older relative? 
- Did you worry that a parent or some other older relative was declining in mental capacity? 
- Did problems experienced by a parent or another older relative place an extra burden on you? 
 
(continued)
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Subscale/Ite
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ms 
Financial stress 
- Did you not have enough money to afford the kind of clothing or food you or your family  
should have? 
- Did you have trouble meeting the monthly payments on bills? 
- Were you confident that your source of income was secure?*
- Did financial problems place an extra burden on you?                                           
Occupational stress 
- Did you feel your work was too dirty, noisy, or dangerous? 
- Did you have more work than you could handle? 
- Were you treated unfairly by others on the job? 
- Did problems experienced by co-workers place an extra burden on you?                     
Ecological stress 
- Did you feel crowded in your present housing situation? 
- Did you worry about crime in your neighborhood? 
- Did you worry about drugs in your neighborhood? 
- Was your neighborhood excessively noisy? 
- Did problems experienced by neighbors place an extra burden on you? 
Physical Stress 
- Did you have trouble getting around?  I mean things like climbing stairs or getting outdoors? 
- Did your health prevent you from doing things you wanted to do? 
- Did any physical disabilities place an extra burden on you? 
 
                                                 
* Reverse scored. 
CSS 
Subscale 
PSS DAS Incomea Educationb Psychological 
Demandc
Coworker 
Supportd
Supervisor 
Supporte
Social 
Supportf
Skill 
Discretiong
Decision 
Authorityh
CSSTOT .36*** -.32*** -.12* -.08 .14† -.24** -.25*** -.28*** -.13† -.20** 
CSSAVG .36*** -.37*** -.18** -.09 .13† -.21** -.24** -.26*** -.13† -.20** 
MAR .18** -.53*** .13* -.03 .14† -.09 -.07 -.09 -.13† -.14† 
PAR .11† .15* -.03 -.11† -.03 -.07 -.03 -.05 -.14† -.19* 
FIL .18** -.05 .00 .05 .07 -.12 -.13† -.15† -.04 -.02 
FIN .22*** -.18** -.22*** -.07 -.03 -.13† -.16* -.17* -.10 -.07 
OCC .35*** -.12† .07 .03 .36***      -.34*** -.21**     -.31*** .10 -.06 
ECO .19** .19** -.28*** -.12* .01 -.09 -.22*** -.19* -.06 -.13† 
PHYS .17** -.17* -.16** -.08 -.01 -.05 -.10 -.09 -.17* -.23** 
† p < .10.  * p < .05.  ** p < .01.  *** p < .001.  
 a, b = Income and education items included in PHHP demographic questionnaire;  c, d, e, f, g, h = Subscales from Job Content Questionnaire (R.A. Karasek, 1985) 
  
APPENDIX B 
Table 37: Pearson correlations of CSS subscales with other relevant stress measures 
105
APPENDIX C: IMT AND PLAQUE CHANGE BY QUANTILES OF CSS SCORES 
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Figure 23: Mean IMT change by quintile of average CSS Score  
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Figure 24: Mean IMT change by quintile of Marital Stress 
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Figure 25: Mean IMT change by quintile of Parental Stress 
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Figure 26: Mean IMT change by quintile of Filial Stress 
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Figure 27: Mean IMT change by quintile of Occupational Stress 
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Figure 28: Mean IMT change by quartile of Financial Stress 
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Figure 29: Mean IMT change by quartile of Ecological Stress 
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Figure 30: Mean IMT among zero, low, medium, and high Physical Stress groups16
                                                 
16 Fifty percent of the sample reported zero Physical Stress.  Thus, for the purposes of presentation, participant data 
were separated into zero and non-zero stress groups.  Bars 1, 2, and 3 represent the lowest, middle, and highest 
tertiles among the non-zero stress group.  
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Figure 31: Mean change in plaque lesion number by quintile of average CSS score 
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Figure 32: Mean change in plaque lesion number by quintile of Marital Stress 
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Figure 33: Mean change in plaque lesion number by quintile of Parental Stress 
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Figure 34: Mean change in plaque lesion number by quintile of Filial Stress 
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Figure 35: Mean change in plaque lesion number by quintile of Occupational Stress 
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Figure 36: Mean change in plaque lesion number by quartile of Financial Stress 
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Figure 37: Mean change in plaque lesion number by quartile of Ecological Stress 
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Figure 38: Mean change in plaque lesions by zero, low, middle, and high Physical Stress 
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APPENDIX D: MEAN CRP AND IL-6 LEVELS BY QUANTILES OF CSS SCORES 
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Figure 39: CRP concentration by quintile of average CSS score 
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Figure 40: CRP concentration by quintile of Marital Stress 
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Figure 41: CRP concentration by quintile of Parental Stress 
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Figure 42: CRP concentration by quintile of Filial Stress 
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Figure 43: CRP concentration by quintile of Occupational Stress 
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Figure 44: CRP concentration by quartile of Financial Stress 
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Figure 45: CRP concentration by quartile of Ecological Stress 
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Figure 46: CRP concentration by zero, low, middle, and high Physical Stress groups 
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Figure 47: IL-6 concentration by quintile of average CSS score 
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Figure 48: IL-6 concentration by quintile of Marital Stress 
 
  118
54321
Parental Stress
2.50
2.00
1.50
1.00
0.50
0.00
M
ea
n 
IL
-6
 
Figure 49: IL-6 concentration by quintile of Parental Stress 
 
54321
Filial Stress
2.50
2.00
1.50
1.00
0.50
0.00
M
ea
n 
IL
-6
 
Figure 50: IL-6 concentration by quintile of Filial Stress 
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Figure 51: IL-6 concentration by quintile of Occupational Stress 
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Figure 52: IL-6 concentration by quartile of Financial Stress 
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Figure 53:  IL-6 concentration by quartile of Ecological Stress 
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Figure 54: IL-6 concentration by zero, low, middle, and high Physical Stress groups 
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APPENDIX E: MAIN ANALYSES STRATIFIED BY SEX 
Table 38: Pearson correlations between CSS scores and carotid artery measures—Men 
 Baseline IMT IMT Change Baseline Plaque Plaque Change 
Average CSS .11 .07 -.07 -.14 
Marital -.04 -.11 -.07 -.09 
Parental -.12 -.01 -.07 -.09 
Filial -.09 .04 -.13 -.06 
Occupational -.02 .07 -.10 -.11 
Financial -.07 -.04 -.08 -.16† 
Ecological -.12 .09 .02 -.12 
Physical .05 .21* .12 .001 
* < .05.  † < .10.       
 
Table 39: Pearson correlations between CSS scores and carotid artery measures—Women 
 Baseline IMT IMT Change Baseline Plaque Plaque Change 
Average CSS .003 .01 .04 .03 
Marital -.08 -.18† -.05 .09 
Parental -.09 -.09 -.04 -.02 
Filial .01 -.07 -.02 -.01 
Occupational -.002 .06 .02 -.10 
Financial .03 .17* .01 .09 
Ecological .08 -.01 .06 -.02 
Physical -.02 .13 .08 .06 
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Table 40: CSS as predictor of 3-year IMT change—Men* 
 
Stress 
 
b
 
t
 
p
Average CSS .03 1.24 .22 
Marital -.01 -.96 .34 
Parental .001 .15 .88 
Filial .003 .88 .38 
Occupational .01 1.00 .32 
Financial .00 -.04 .97 
Ecological .01 1.41 .16 
Physical .02 2.35 .02 
*Includes controls for baseline IMT, age 
 
Table 41: CSS as predictor of 3-year IMT change—Women* 
 
Stress 
 
b
 
t
 
p
Average CSS -.02 -.97 .34 
Marital -.01 -1.79 .08 
Parental -.003 -.98 .33 
Filial -.003 -1.47 .14 
Occupational -.001 -.20 .84 
Financial .005 1.29 .20 
Ecological -.002 -.75 .46 
Physical .004 .60 .55 
*Includes controls for baseline IMT, age, use of prescription pain medication 
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Table 42: CSS as predictor of 3-year plaque change—Men 
 
Stress 
 
Odds Ratio 
 
Confidence Interval 
 
p
Average CSS .71 .36, 1.39 .31 
Marital .90 .75, 1.08 .28 
Parental .95 .84, 1.08 .42 
Filial 1.00 .92, 1.08 .91 
Occupational .98 .82, 1.17 .81 
Financial .92 .82, 1.03 .14 
Ecological .95 .85, 1.06 .35 
Physical 1.02 .82, 1.27 .85 
*Includes controls for baseline plaque, BMI, pulse pressure 
 
Table 43: CSS as predictor of 3-year plaque change—Women 
 
Stress 
 
Odds Ratio 
 
Confidence Interval 
 
p 
Average CSS .94 .46, 1.90 .86 
Marital 1.08 .91, 1.28 .39 
Parental .98 .87, 1.10 .68 
Filial 1.00 .92, 1.07 .91 
Occupational .89 .73, 1.08 .23 
Financial 1.06 .92, 1.23 .41 
Ecological .98 .87, 1.09 .67 
Physical .99 .78, 1.26 .94 
*Includes controls for baseline plaque, LDL cholesterol, use of prescription pain medication  
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Table 44: Correlations between inflammatory markers and carotid artery measures—Men 
  
Baseline IMT 
 
IMT Change 
 
Baseline Plaque 
 
Plaque Change 
CRP .04 -.08 .13 .06 
IL-6 -.05 -.01 .10 -.08 
 
Table 45: Correlations between inflammatory markers and carotid artery measures—Women 
  
Baseline IMT 
 
IMT Change 
 
Baseline Plaque 
 
Plaque Change 
CRP .10 .03 -.05 -.05 
IL-6 .07 .03 .06 -.11 
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Table 46: Correlations between CSS scores and inflammatory markers—Men 
 
Stress 
 
CRP 
 
IL-6 
Average CSS .11 .04 
Marital .11 -.03 
Parental -.06 -.18* 
Filial -.12 -.04 
Occupational -.12 .07 
Financial .22* .02 
Ecological .09 .13 
Physical .22* .19* 
* < .05.  † < .10.   
 
Table 47: Correlations between CSS scores and inflammatory markers—Women 
 
Stress 
 
CRP 
 
IL-6 
Average CSS .16† .07 
Marital .04 .18† 
Parental .09 .03 
Filial .13 .02 
Occupational .10 -.08 
Financial -.05 -.03 
Ecological .12 .14† 
Physical .12 .06 
* < .05.  † < .10.   
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Table 48: CSS as predictor of baseline CRP—Men* 
 
Stress 
 
b
 
t
 
p
Average CSS .01 .31 .76 
Marital .01 .73 .47 
Parental -.01 -1.49 .14 
Filial -.001 -.30 .77 
Occupational -.01 -1.13 .26 
Financial .01 1.87 .06 
Ecological .003 .53 .60 
Physical .003 .21 .83 
* Includes controls for BMI, smoking status, use of prescription pain medication 
 
Table 49: CSS as predictor of baseline CRP—Women* 
 
Stress 
 
b
 
t
 
p
Average CSS .04 1.17 .24 
Marital .003 .28 .78 
Parental .01 .86 .39 
Filial .01 1.82 .07 
Occupational .001 .13 .90 
Financial -.01 -.68 .50 
Ecological .01 .91 .37 
Physical -.001 -.12 .90 
* Includes controls for BMI, triglycerides 
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Table 50: CSS as predictor of baseline IL-6—Men* 
 
Stress 
 
b
 
t
 
p
Average CSS -.01 -.39 .70 
Marital -.01 -1.03 .31 
Parental -.01 -2.09 .04 
Filial -.001 .54 .59 
Occupational .001 .25 .81 
Financial .003 .75 .46 
Ecological -.001 -.26 .80 
Physical -.001 -.18 .86 
* Includes controls for BMI, smoking status, rheumatologic condition 
 
Table 51:  CSS as predictor of baseline IL-6—Women* 
 
Stress 
 
b
 
t
 
p
Average CSS -.004 -.20 .84 
Marital .01 1.16 .25 
Parental -.001 -.22 .83 
Filial .00 .10 .92 
Occupational -.01 -1.36 .18 
Financial -.002 -.68 .50 
Ecological .004 1.25 .21 
Physical -.005 -.80 .43 
* Includes controls for BMI, triglycerides 
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